###begin article-title 0
###xml 4 5 4 5 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 93 108 <span type="species:ncbi:11082">West Nile virus</span>
Ly6c+ "inflammatory monocytes" are microglial precursors recruited in a pathogenic manner in West Nile virus encephalitis
###end article-title 0
###begin p 1
###xml 35 62 35 62 <email xmlns:xlink="http://www.w3.org/1999/xlink">nickk@pathology.usyd.edu.au</email>
CORRESPONDENCE Nicholas J.C. King: nickk@pathology.usyd.edu.au
###end p 1
###begin p 2
This article is distributed under the terms of an Attribution-Noncommercial-Share Alike-No Mirror Sites license for the first six months after the publication date (see ). After six months it is available under a Creative Commons License (Attribution-Noncommercial-Share Alike 3.0 Unported license, as described at ).
###end p 2
###begin p 3
###xml 112 115 112 115 <sup xmlns:xlink="http://www.w3.org/1999/xlink">int</sup>
###xml 121 122 121 122 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 128 129 128 129 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 323 324 323 324 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 329 331 329 331 <sup xmlns:xlink="http://www.w3.org/1999/xlink">lo</sup>
###xml 338 339 338 339 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 364 366 364 366 <sup xmlns:xlink="http://www.w3.org/1999/xlink">hi</sup>
###xml 371 373 371 373 <sup xmlns:xlink="http://www.w3.org/1999/xlink">hi</sup>
###xml 378 379 378 379 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 604 605 604 605 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 631 632 631 632 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 637 638 637 638 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 783 785 783 785 <sup xmlns:xlink="http://www.w3.org/1999/xlink">hi</sup>
###xml 791 792 791 792 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1087 1088 1087 1088 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 12 27 <span type="species:ncbi:11082">West Nile virus</span>
###xml 29 32 <span type="species:ncbi:11082?0.9877551020408163">WNV</span>
###xml 855 858 <span type="species:ncbi:11082?0.9877551020408163">WNV</span>
###xml 964 967 <span type="species:ncbi:11082?0.9877551020408163">WNV</span>
###xml 1119 1122 <span type="species:ncbi:11082?0.9877551020408163">WNV</span>
###xml 1281 1284 <span type="species:ncbi:11082?0.9877551020408163">WNV</span>
###xml 1338 1341 <span type="species:ncbi:11082?0.9877551020408163">WNV</span>
In a lethal West Nile virus (WNV) model, central nervous system infection triggered a threefold increase in CD45int/CD11b+/CD11c- microglia at days 6-7 postinfection (p.i.). Few microglia were proliferating, suggesting that the increased numbers were derived from a migratory precursor cell. Depletion of "circulating" (Gr1-(Ly6Clo)CX3CR1+) and "inflammatory" (Gr1hi/Ly6Chi/CCR2+) classical monocytes during infection abrogated the increase in microglia. C57BL/6 chimeras reconstituted with cFMS-enhanced green fluorescent protein (EGFP) bone marrow (BM) showed large numbers of peripherally derived (GFP+) microglia expressing GR1+(Ly6C+) at day 7 p.i., suggesting that the inflammatory monocyte is a microglial precursor. This was confirmed by adoptive transfer of labeled BM (Ly6Chi/CD115+) or circulating inflammatory monocytes that trafficked to the WNV-infected brain and expressed a microglial phenotype. CCL2 is a chemokine that is highly expressed during WNV infection and important in inflammatory monocyte trafficking. Neutralization of CCL2 not only reduced the number of GFP+ microglia in the brain during WNV infection but prolonged the life of infected animals. Therefore, CCL2-dependent inflammatory monocyte migration is critical for increases in microglia during WNV infection and may also play a pathogenic role during WNV encephalitis.
###end p 3
###begin p 4
###xml 222 225 <span type="species:ncbi:11082?0.9877551020408163">WNV</span>
###xml 227 242 <span type="species:ncbi:11082">West Nile virus</span>
Abbreviations used: ANOVA, analysis of variance; BBB, blood-brain barrier; C-L, clodronate-loaded; CNS, central nervous system; D-L, Dil-labeled; H&E, hematoxylin and eosin; IHC, immunohistochemistry; p.i., postinfection; WNV, West Nile virus.
###end p 4
###begin p 5
D.R. Getts' present address is Department of Microbiology and Immunology, Northwestern University, Chicago, IL.
###end p 5
###begin p 6
B. Shrestha's present address is Department of Medicine, Washington University School of Medicine, St. Louis, MO 63110.
###end p 6
###begin p 7
M. Muller's present address is Department of Neurology, University of Bonn, 53105 Bonn, Germany.
###end p 7
###begin p 8
###xml 228 229 228 229 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib1">1</xref>
###xml 230 231 230 231 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib4">4</xref>
###xml 466 467 466 467 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib5">5</xref>
###xml 468 470 468 470 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib10">10</xref>
The mechanism resulting in increased numbers of microglia in the central nervous system (CNS) during inflammation has long been debated. Microglia have been shown to proliferate in situ in several synthetic inflammatory models (1-4). In contrast, it is suggested that microglia can differentiate from blood-derived precursors that migrate into the CNS; however, recent reports suggest that this can only occur after radiation-induced "preconditioning" of the brain (5-10). Whether viral infection initiates events resulting in microglial recruitment from the periphery is unknown.
###end p 8
###begin p 9
###xml 100 102 100 102 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib11">11</xref>
###xml 272 274 272 274 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib13">13</xref>
###xml 381 383 381 383 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib12">12</xref>
###xml 385 387 385 387 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib14">14</xref>
###xml 425 427 425 427 <sup xmlns:xlink="http://www.w3.org/1999/xlink">hi</sup>
###xml 467 469 467 469 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib12">12</xref>
###xml 470 472 470 472 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib14">14</xref>
###xml 629 631 629 631 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib15">15</xref>
###xml 633 635 633 635 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib16">16</xref>
###xml 775 776 775 776 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib6">6</xref>
###xml 778 780 778 780 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib13">13</xref>
###xml 782 784 782 784 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib17">17</xref>
###xml 875 876 875 876 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 878 879 878 879 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1</sub>
###xml 975 977 975 977 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib12">12</xref>
During embryonic development, microglia populate the CNS from myeloid lineage precursors in the BM (11). Much is known about early monocyte lineage precursors, but the differentiation to downstream effector populations in the adult remain poorly defined. Geissman et al. (13) have described two major subsets in the peripheral blood, the "inflammatory" and "circulating" monocyte (12, 14). Inflammatory monocytes express Ly6Chi (Gr1) and the chemokine receptor CCR2 (12-14). CCR2 and one of its ligands, CCL2, are evidently important in both emigration of these monocytes from the BM and their immigration into inflamed tissues (15, 16). Inflammatory monocytes migrate to the spleen and skin, where they can differentiate into macrophages and Langerhans cells, respectively (6, 13, 17). Circulating monocytes, identified by their low expression of Ly6C in conjunction with CX3CR1, are thought to be important in replenishing tissue macrophages during homeostatic conditions (12).
###end p 9
###begin p 10
###xml 329 331 329 331 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib18">18</xref>
###xml 332 334 332 334 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib20">20</xref>
###xml 380 381 380 381 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 386 387 386 387 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 477 479 477 479 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib21">21</xref>
###xml 481 483 481 483 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib22">22</xref>
###xml 569 571 569 571 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib19">19</xref>
###xml 573 575 573 575 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib23">23</xref>
###xml 747 749 747 749 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib24">24</xref>
###xml 1004 1006 1004 1006 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib25">25</xref>
###xml 1007 1009 1007 1009 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib28">28</xref>
###xml 1196 1198 1196 1198 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib26">26</xref>
###xml 1200 1202 1200 1202 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib29">29</xref>
###xml 1203 1205 1203 1205 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib34">34</xref>
###xml 28 43 <span type="species:ncbi:11082">West Nile virus</span>
###xml 45 48 <span type="species:ncbi:11082?0.9877551020408163">WNV</span>
###xml 272 275 <span type="species:ncbi:11082?0.9877551020408163">WNV</span>
###xml 459 462 <span type="species:ncbi:11082?0.9877551020408163">WNV</span>
###xml 541 544 <span type="species:ncbi:11082?0.9877551020408163">WNV</span>
In this study, we have used West Nile virus (WNV) to investigate the in vivo trafficking and differentiation of monocyte/microglia during lethal encephalitis. Although it is clear from previous work that several elements of the systemic immune system work together during WNV infection to control viral growth and dissemination (18-20), it is also apparent that infiltrating CD11b+/CD45+ myeloid cells contribute to underlying immunopathology observed during WNV encephalitis (21, 22). Although activated microglia have been observed during WNV infection of the brain (19, 23), the contribution of microglia to immunopathology is unknown. Microglia are immune-competent cells of the CNS, comprising up to 20% of the total rodent glial population (24). Resting microglia usually exhibit a ramified dendritic morphology and express low levels of cell surface immune molecules. However, alterations in the microenvironment can result in rapid activation. Activated microglia acquire an amoeboid morphology (25-28), develop an increase in phagocytic ability, exhibit enhanced migratory capacity within the brain, and increase their expression of cell surface glycoproteins including CD45 and MHC-II (26, 29-34).
###end p 10
###begin p 11
###xml 73 75 73 75 <sup xmlns:xlink="http://www.w3.org/1999/xlink">hi</sup>
###xml 59 63 <span type="species:ncbi:10090">mice</span>
###xml 144 147 <span type="species:ncbi:11082?0.9877551020408163">WNV</span>
###xml 310 313 <span type="species:ncbi:11082?0.9877551020408163">WNV</span>
###xml 323 327 <span type="species:ncbi:10090">mice</span>
###xml 357 360 <span type="species:ncbi:11082?0.9877551020408163">WNV</span>
###xml 435 439 <span type="species:ncbi:10090">mice</span>
###xml 582 585 <span type="species:ncbi:11082?0.9877551020408163">WNV</span>
In this paper, we show for the first time in nonirradiated mice that Ly6Chi inflammatory monocytes migrate in a CCL2-dependent fashion into the WNV-infected CNS, where they develop a microglial phenotype. Inhibition of microglial immigration seen after CCL2 neutralization correlated with enhanced survival of WNV-infected mice. Paradoxically, the titer of WNV in the CCL2-neutralized brains was similar to that observed in nontreated mice, indicating that pathogenesis is not directly related to viral load and implicating CCL2-mediated microglial migration in the pathogenesis of WNV encephalitis.
###end p 11
###begin title 12
RESULTS
###end title 12
###begin title 13
###xml 65 68 <span type="species:ncbi:11082?0.9877551020408163">WNV</span>
Microglia become activated and increase in number in response to WNV infection
###end title 13
###begin p 14
###xml 279 280 275 276 <sc xmlns:xlink="http://www.w3.org/1999/xlink">d</sc>
###xml 401 403 397 399 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib35">35</xref>
###xml 452 453 444 445 <sc xmlns:xlink="http://www.w3.org/1999/xlink">d</sc>
###xml 717 732 709 724 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig1" ref-type="fig">Fig. 1, A and B</xref>
###xml 896 904 888 896 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig1" ref-type="fig">Fig. 1 B</xref>
###xml 1232 1247 1224 1239 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig1" ref-type="fig">Fig. 1, C and D</xref>
###xml 1444 1459 1436 1451 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig1" ref-type="fig">Fig. 1, E and F</xref>
###xml 1462 1464 1454 1456 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib36">36</xref>
###xml 32 36 <span type="species:ncbi:10090">mice</span>
###xml 64 67 <span type="species:ncbi:11082?0.9877551020408163">WNV</span>
###xml 100 103 <span type="species:ncbi:11082?0.9877551020408163">WNV</span>
Sections of brains from C57BL/6 mice infected intranasally with WNV were labeled with GS-lectin and WNV NS-1 antibody to determine the extent of microglial activation and cellular infection. In normal brains, resting microglia exhibit a ramified morphology and express few alpha-d-galactose residues on their cell surface, making them difficult to detect by immunohistochemistry (IHC) with GS-lectin (35). However, upon activation, expression of alpha-d-galactose on microglia increases and can be readily detected by IHC. Microglia showed prominent lectin staining in the outer layers of the olfactory bulb on day 3 postinfection (p.i.), corresponding to the appearance of NS-1 staining in this region of the brain (Fig. 1, A and B). Between days 3 and 7 p.i., the morphology of microglia changed. Early activated microglia displayed a dendritic morphology and stained intensely with GS-lectin (Fig. 1 B). However, with progression of infection, as evident by the spread of NS-1 immunoreactivity throughout the brain (Fig. S1, available at ), microglia with enlarged cell bodies and retracted processes (stout morphology), as well as those with amoeboid morphology, including rod-shaped and round phagocytic forms, became evident (Fig. 1, C and D; Fig. S1). Rod-shaped microglia were found predominantly in clusters around neurons or near perivascular cuffs and resembled previously described perivascular microglia, also known as Mato cells (Fig. 1, E and F) (36).
###end p 14
###begin p 15
###xml 0 51 0 51 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Kinetics of microglial change during WNV infection.</bold>
###xml 946 948 945 947 <sup xmlns:xlink="http://www.w3.org/1999/xlink">lo</sup>
###xml 1056 1059 1055 1058 <sup xmlns:xlink="http://www.w3.org/1999/xlink">int</sup>
###xml 1433 1436 1432 1435 <sup xmlns:xlink="http://www.w3.org/1999/xlink">int</sup>
###xml 1626 1628 1625 1627 <sup xmlns:xlink="http://www.w3.org/1999/xlink">lo</sup>
###xml 1848 1850 1845 1847 <sup xmlns:xlink="http://www.w3.org/1999/xlink">lo</sup>
###xml 1871 1874 1868 1871 <sup xmlns:xlink="http://www.w3.org/1999/xlink">int</sup>
###xml 1876 1879 1873 1876 <sup xmlns:xlink="http://www.w3.org/1999/xlink">###</sup>
###xml 37 40 <span type="species:ncbi:11082?0.9877551020408163">WNV</span>
###xml 52 55 <span type="species:ncbi:11082?0.9877551020408163">WNV</span>
###xml 1791 1795 <span type="species:ncbi:10090">mice</span>
Kinetics of microglial change during WNV infection. WNV NS-1 protein first appeared in the outermost layer of the olfactory bulb on day 3 p.i. (A, arrowheads). Early activated microglia, identified by lectin staining and dendritic morphology, were concurrently detected in the outermost layer on day 3 p.i. (B, arrowheads and enlarged inset of the arrowed box) but nowhere else in the brain. On days 6 and 7 p.i. (C and D), scattered activated microglia (arrows and enlarged inset of the arrowed box) exhibited both amoeboid and intermediate activated morphology in the olfactory bulb. In the brain parenchyma, lectin-positive cells with amoeboid morphology (arrows and enlarged insets of arrowed boxes) were observed surrounding the blood vessels on days 6 (E) and 7 (F) p.i. Bars, 100 muM. Flow cytometry of leukocytes isolated from the whole brain in mock infected (G) showed a predominant population of resting microglia with a classical CD45lo phenotype (R1). By day 7 p.i., significant numbers of activated microglia could be identified by their CD45int expression, as indicated by R2 (H). Analysis of the total microglial population for Ly6G (I) and Ly6C (J) expression showed increased Ly6C expression on activated microglia but no Ly6G expression on resting or activated microglia. Enumeration of total microglia at days 0, 3, 5, 6, and 7 p.i. showed a major increase between days 6 and 7 p.i. (K). Increased numbers of CD45int (activated) microglia could be detected as early as day 3 p.i. (K), with numbers increasing dramatically between days 5 and 7. These changes were temporally independent of decreases in CD45lo (resting) microglial numbers, which declined from day 3 p.i. onwards. Data shown are means +/- SD and are representative of three experiments with at least three mice per group. ***, P < 0.001, comparing day-7 p.i. CD45lo with day-7 p.i. CD45int; ###, P < 0.001, comparing day-7 p.i. total microglia with days 0, 5, or 6 p.i. using one-way analysis of variance (ANOVA) with a Tukey-Kramer posttest.
###end p 15
###begin p 16
###xml 359 361 359 361 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib30">30</xref>
###xml 472 474 472 474 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib26">26</xref>
###xml 521 523 521 523 <sup xmlns:xlink="http://www.w3.org/1999/xlink">lo</sup>
###xml 651 654 651 654 <sup xmlns:xlink="http://www.w3.org/1999/xlink">int</sup>
###xml 792 794 792 794 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib30">30</xref>
Microglia express many markers in common with macrophages. As such, many studies have failed to distinguish correctly between microglia and macrophages. In this study, we used the positive expression of CD11b in conjunction with the differential expression of CD45 antigen on the cell surface using flow cytometry, as originally described by Sedgwick et al. (30). In this way, resting microglia can be differentiated from activated microglia, as well as from macrophages (26). Ramified or resting microglia express a CD45lo phenotype, increasing their cell surface expression to an intermediate (int) level upon activation. Importantly, activated CD45int microglia express a lower level of CD45 than macrophages in the CNS, enabling these two cell types to be differentiated from each other (30).
###end p 16
###begin p 17
###xml 164 166 164 166 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib26">26</xref>
###xml 168 170 168 170 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib30">30</xref>
###xml 173 181 173 181 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig1" ref-type="fig">Fig. 1 G</xref>
###xml 312 314 312 314 <sup xmlns:xlink="http://www.w3.org/1999/xlink">lo</sup>
###xml 353 356 353 356 <sup xmlns:xlink="http://www.w3.org/1999/xlink">int</sup>
###xml 467 468 467 468 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 473 475 473 475 <sup xmlns:xlink="http://www.w3.org/1999/xlink">hi</sup>
###xml 489 497 489 497 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig1" ref-type="fig">Fig. 1 H</xref>
###xml 668 683 668 683 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig1" ref-type="fig">Fig. 1, I and J</xref>
###xml 741 744 741 744 <sup xmlns:xlink="http://www.w3.org/1999/xlink">int</sup>
###xml 85 90 <span type="species:ncbi:10090">mouse</span>
###xml 237 240 <span type="species:ncbi:11082?0.9877551020408163">WNV</span>
As expected, the expression of CD45 on leukocytes isolated either from mock-infected mouse brains or at day 0 p.i. was uniformly low (resting microglia [references 26, 30]; Fig. 1 G and not depicted). By day 7 p.i., brains infected with WNV displayed a heterogenous CD45 versus CD11b profile. Relatively few CD45lo microglia were present, whereas a CD45int (activated microglia) population was present and could be distinguished from a significant population of CD11b+/CD45hi macrophages (Fig. 1 H). The increase in CD45 expression on microglia is indicative of activation of these cells. Analysis of Ly6G and Ly6C expression on these resting and activated microglia (Fig. 1, I and J) showed a significant increase in Ly6C expression on CD45int microglia. The absence of Ly6G expression confirms that these cells are not granulocytes.
###end p 17
###begin p 18
###xml 123 126 123 126 <sup xmlns:xlink="http://www.w3.org/1999/xlink">int</sup>
###xml 138 153 138 153 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig1" ref-type="fig">Fig. 1, H and K</xref>
###xml 193 199 193 199 <sup xmlns:xlink="http://www.w3.org/1999/xlink">lo+int</sup>
###xml 330 338 330 338 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig1" ref-type="fig">Fig. 1 K</xref>
###xml 425 433 425 433 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig1" ref-type="fig">Fig. 1 K</xref>
###xml 439 442 439 442 <sup xmlns:xlink="http://www.w3.org/1999/xlink">int</sup>
###xml 595 598 595 598 <sup xmlns:xlink="http://www.w3.org/1999/xlink">int</sup>
###xml 679 681 679 681 <sup xmlns:xlink="http://www.w3.org/1999/xlink">lo</sup>
###xml 792 795 792 795 <sup xmlns:xlink="http://www.w3.org/1999/xlink">int</sup>
###xml 55 58 <span type="species:ncbi:11082?0.9877551020408163">WNV</span>
###xml 1140 1143 <span type="species:ncbi:11082?0.9877551020408163">WNV</span>
Enumeration of microglia by flow cytometry showed that WNV infection resulted in an increase in the absolute number of CD45int microglia (Fig. 1, H and K). Overall microglial cell numbers (CD45lo+int) were not statistically different until day 7 p.i. By day 7 p.i., the total numbers of microglia increased by three- to fourfold (Fig. 1 K). The differential contributions of resting and activated microglia are also shown in Fig. 1 K. CD45int cells, virtually absent on day 0 p.i., were found in low numbers on day 3 p.i., correlating with the increase in lectin labeling by IHC. Numbers of CD45int microglia had increased significantly by day 7 p.i. In contrast, numbers of CD45lo microglia had significantly decreased at day 6 compared with day 3 p.i. and were significantly lower than CD45int microglial numbers at day 7 p.i. Because numbers of total microglia at day 6 p.i. were not significantly different from those of the earlier time points, this suggests that resting microglia are increasing their CD45 expression (as previously described); however, the significant increase in overall microglial numbers in the brain by day 7 in WNV infection argues that there is either in situ microglial proliferation or external recruitment.
###end p 18
###begin title 19
###xml 57 60 <span type="species:ncbi:11082?0.9877551020408163">WNV</span>
Microglia do not proliferate significantly in situ after WNV infection
###end title 19
###begin p 20
###xml 118 119 118 119 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib1">1</xref>
###xml 120 121 120 121 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib4">4</xref>
###xml 123 124 123 124 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib9">9</xref>
###xml 126 128 126 128 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib33">33</xref>
###xml 130 132 130 132 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib34">34</xref>
###xml 134 136 134 136 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib37">37</xref>
###xml 138 140 138 140 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib38">38</xref>
###xml 283 284 283 284 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 178 182 <span type="species:ncbi:10090">mice</span>
###xml 458 461 <span type="species:ncbi:11082?0.9877551020408163">WNV</span>
###xml 471 475 <span type="species:ncbi:10090">mice</span>
As mentioned, several stimuli may induce microglial proliferation, which is measurable by nuclear BrdU incorporation (1-4, 9, 33, 34, 37, 38). However, in some of these studies, mice were exposed to BrdU for several days. This makes it impossible to exclude the possibility that BrdU+ microglia in these models arose from precursor cells that had proliferated in peripheral sites, such as the BM, and subsequently migrated to the brain. Therefore, groups of WNV-infected mice were pulsed i.v. with BrdU for 3 h on either day 6 or 7 p.i., when maximal increases in microglia were occurring, and killed immediately after the pulse period.
###end p 20
###begin p 21
###xml 69 70 69 70 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 103 104 103 104 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 278 297 278 297 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig2" ref-type="fig">Fig. 2, A, B, and D</xref>
###xml 364 372 364 372 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig2" ref-type="fig">Fig. 2 C</xref>
###xml 499 507 499 507 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig2" ref-type="fig">Fig. 2 D</xref>
###xml 639 640 627 628 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 656 671 644 659 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig2" ref-type="fig">Fig. 2, E and F</xref>
###xml 751 752 739 740 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 967 975 955 963 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig1" ref-type="fig">Fig. 1 K</xref>
###xml 3 6 <span type="species:ncbi:11082?0.9877551020408163">WNV</span>
###xml 16 20 <span type="species:ncbi:10090">mice</span>
###xml 151 155 <span type="species:ncbi:10090">mice</span>
###xml 323 326 <span type="species:ncbi:11082?0.9877551020408163">WNV</span>
###xml 336 340 <span type="species:ncbi:10090">mice</span>
###xml 407 411 <span type="species:ncbi:10090">mice</span>
###xml 616 619 <span type="species:ncbi:11082?0.9877551020408163">WNV</span>
###xml 766 769 <span type="species:ncbi:11082?0.9877551020408163">WNV</span>
###xml 779 783 <span type="species:ncbi:10090">mice</span>
In WNV-infected mice on either day 6 or 7 p.i., the frequency of BrdU+ cells was low. Of the total BrdU+ cells counted in brain sections from infected mice, >70% were localized within perivascular cuffs on both days 6 and 7 p.i., with very few observed in the brain parenchyma (Fig. 2, A, B, and D). Labeling in day-7 p.i. WNV-infected mice not treated with BrdU (Fig. 2 C) or in BrdU-treated mock-infected mice (not depicted) showed virtually no positively labeled cells in any areas of the brain (Fig. 2 D). This was further supported by flow-cytometric analysis, which showed that approximately1% of microglia in WNV infection were BrdU+ at day 7 p.i. (Fig. 2, E and F; and Fig. S2, available at ). The combination of the very low frequency of BrdU+ microglia in WNV-infected mice, their predominantly perivascular location during the period of greatest increase in activated microglia, and the relatively small reduction in absolute numbers of resting microglia (Fig. 1 K) makes it unlikely that in situ proliferation can account for the large numbers of activated microglia seen at day 7 p.i.
###end p 21
###begin p 22
###xml 0 93 0 93 <bold xmlns:xlink="http://www.w3.org/1999/xlink">There is little cellular proliferation and negligible BBB disruption during WNV encephalitis.</bold>
###xml 185 186 185 186 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 374 375 374 375 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 435 436 435 436 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 658 659 658 659 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 76 79 <span type="species:ncbi:11082?0.9877551020408163">WNV</span>
###xml 94 98 <span type="species:ncbi:10090">Mice</span>
###xml 306 310 <span type="species:ncbi:10090">mice</span>
###xml 332 335 <span type="species:ncbi:11082?0.9877551020408163">WNV</span>
###xml 345 349 <span type="species:ncbi:10090">mice</span>
###xml 602 605 <span type="species:ncbi:11082?0.9877551020408163">WNV</span>
###xml 633 637 <span type="species:ncbi:10090">mice</span>
###xml 737 740 <span type="species:ncbi:11082?0.9877551020408163">WNV</span>
###xml 750 754 <span type="species:ncbi:10090">mice</span>
###xml 775 779 <span type="species:ncbi:10090">mice</span>
###xml 830 834 <span type="species:ncbi:10090">mice</span>
###xml 879 882 <span type="species:ncbi:11082?0.9877551020408163">WNV</span>
###xml 892 896 <span type="species:ncbi:10090">mice</span>
###xml 975 979 <span type="species:ncbi:10090">mice</span>
###xml 1235 1239 <span type="species:ncbi:10090">mice</span>
There is little cellular proliferation and negligible BBB disruption during WNV encephalitis. Mice were treated with BrdU for 3 h before sacrifice. Routine IHC for BrdU showed that BrdU+ cells localized predominantly to the perivascular cuff on days 6 (A) and 7 (B) p.i. This was not seen in mock-infected mice or mock BrdU-treated WNV-infected mice (C). Enumeration of BrdU+ cells on histological sections showed that >70% of all BrdU+ cells were perivascularly localized (D). The percentage of proliferating microglia was also determined by flow cytometry (E and F). Approximately 1% of microglia in WNV-infected and mock-infected mice were seen to be BrdU+ (E and F). To test the status of the BBB, fibrinogen IHC was performed on 10 WNV-infected mice and 5 mock-infected mice. Fibrinogen was not detected in any mock-infected mice at day 7 p.i. (0/5; G-I). Furthermore, 7/10 WNV-infected mice also failed to exhibit any evidence of fibrinogen leakage (J-L). In the three mice where fibrinogen labeling was detected, staining was scant and limited to the luminal surface of vessels (M-O, 20x; P-R, 100x images of M-O). Data shown are means +/- SD. Data from BrdU experiments are representative of two experiments with at least five mice per group. Bars: (A-C) 100 muM; (G-O) 200 muM; (P-R) 50 muM.
###end p 22
###begin title 23
Microglial increases are not caused by breakdown of the blood-brain barrier (BBB)
###end title 23
###begin p 24
###xml 444 446 444 446 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib39">39</xref>
###xml 447 449 447 449 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib44">44</xref>
###xml 629 640 629 640 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig2" ref-type="fig">Fig. 2, J&#8211;L</xref>
###xml 765 776 765 776 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig2" ref-type="fig">Fig. 2, M&#8211;R</xref>
###xml 1059 1061 1059 1061 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib45">45</xref>
###xml 91 94 <span type="species:ncbi:11082?0.9877551020408163">WNV</span>
###xml 104 109 <span type="species:ncbi:10090">mouse</span>
###xml 205 208 <span type="species:ncbi:11082?0.9877551020408163">WNV</span>
###xml 465 469 <span type="species:ncbi:10090">mice</span>
###xml 484 487 <span type="species:ncbi:11082?0.9877551020408163">WNV</span>
###xml 564 568 <span type="species:ncbi:10090">mice</span>
###xml 688 692 <span type="species:ncbi:10090">mice</span>
###xml 928 932 <span type="species:ncbi:10090">mice</span>
###xml 1044 1047 <span type="species:ncbi:11082?0.9877551020408163">WNV</span>
###xml 1088 1091 <span type="species:ncbi:11082?0.9877551020408163">WNV</span>
Breakdown of the BBB may explain the significant burst in numbers of microglia seen in the WNV-infected mouse brain between days 6 and 7 p.i. We investigated the status of the BBB by fibrinogen IHC in the WNV-infected brain at the peak of disease (day 7 p.i.). The presence of fibrinogen has previously been described to detect microvascular leakage in the brain during several distinct neuroinflammatory models and on postmortem brain tissue (39-44). Although all mice infected with WNV had severe leukocyte infiltration and perivascular cuffing, 70% of infected mice (7/10) displayed no detectable fibrinogen immunoreactivity (Fig. 2, J-L), whereas fibrinogen staining in the remaining mice was extremely scant and limited to the luminal side of the endothelium (Fig. 2, M-R). In addition, administration of Evans blue, 1 h before sacrifice on day 7 p.i., showed that BBB breakdown was similarly sporadic, with two out of six mice showing some Evans blue leakage into the brain (Fig. S3, available at ). Therefore, similar to other routes of WNV infection (45), the intranasal route of WNV infection causes sporadic BBB breakdown.
###end p 24
###begin title 25
###xml 52 55 <span type="species:ncbi:11082?0.9877551020408163">WNV</span>
###xml 65 69 <span type="species:ncbi:10090">mice</span>
Microglial numbers are reduced in monocyte-depleted WNV-infected mice
###end title 25
###begin p 26
###xml 317 318 317 318 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 325 327 325 327 <sup xmlns:xlink="http://www.w3.org/1999/xlink">hi</sup>
###xml 339 341 339 341 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib13">13</xref>
###xml 343 345 343 345 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib14">14</xref>
###xml 347 349 347 349 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib46">46</xref>
###xml 927 929 919 921 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib47">47</xref>
###xml 931 933 923 925 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib48">48</xref>
###xml 1037 1048 1029 1040 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig3" ref-type="fig">Fig. 3, A&#8211;L</xref>
###xml 1195 1206 1187 1198 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig3" ref-type="fig">Fig. 3, M&#8211;X</xref>
###xml 1358 1369 1350 1361 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig3" ref-type="fig">Fig. 3, M&#8211;T</xref>
###xml 1462 1473 1454 1465 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig3" ref-type="fig">Fig. 3, U&#8211;X</xref>
###xml 1498 1506 1490 1498 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig3" ref-type="fig">Fig. 3 X</xref>
###xml 1923 1925 1915 1917 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib49">49</xref>
###xml 420 423 <span type="species:ncbi:11082?0.9877551020408163">WNV</span>
###xml 433 437 <span type="species:ncbi:10090">mice</span>
###xml 490 494 <span type="species:ncbi:10090">mice</span>
###xml 593 597 <span type="species:ncbi:10090">mice</span>
###xml 652 656 <span type="species:ncbi:10090">mice</span>
###xml 748 751 <span type="species:ncbi:11082?0.9877551020408163">WNV</span>
###xml 1018 1021 <span type="species:ncbi:11082?0.9877551020408163">WNV</span>
###xml 1031 1035 <span type="species:ncbi:10090">mice</span>
###xml 1180 1183 <span type="species:ncbi:11082?0.9877551020408163">WNV</span>
###xml 1352 1356 <span type="species:ncbi:10090">mice</span>
###xml 1443 1446 <span type="species:ncbi:11082?0.9877551020408163">WNV</span>
###xml 1456 1460 <span type="species:ncbi:10090">mice</span>
###xml 1492 1496 <span type="species:ncbi:10090">mice</span>
Microglial infiltration into the brain has been suggested to occur in several models; however, this has not been addressed during viral encephalitis. Recruitment from the peripheral blood to sites of infection in organs other than the brain and their differentiation into effector cells has been shown to involve Ly6C+ or Gr1hi monocytes (13, 14, 46). Interestingly, 31.3 +/- 7% of activated microglia expressed Ly6C in WNV-infected mice, compared with 12 +/- 0.8% in mock-infected control mice (P < 0.001). Furthermore, 7.6 +/- 1.5% of resting microglia expressed detectable Ly6C in infected mice, compared with 0.32 +/- 0.2% in mock-infected control mice (P < 0.001). To determine whether blood-derived monocytes are microglial precursors during WNV infection, we depleted blood monocytes with clodronate-loaded (C-L) liposomes. It has previously been shown that liposomes do not deplete macrophages in the brain parenchyma (47, 48). Although perivascular cuffs were evidently resistant to C-L liposome depletion in WNV-infected mice (Fig. 3, A-L), we additionally used Dil-labeled (D-L) liposomes to further confirm visually that liposomes do not have access to the CNS during WNV infection (Fig. 3, M-X and top right insets). After injection, D-L liposomes were abundantly localized to the splenic marginal zones in both infected and mock-infected mice (Fig. 3, M-T). In contrast, no D-L liposomes were found in the brains of either day-7 WNV-infected mice (Fig. 3, U-X) or mock-infected mice (Fig. 3 X, bottom left inset), confirming that liposomes do not cross the BBB. This further supports the data in the previous section, indicating that little or no BBB breakdown occurs in this model. Overall, these data support previously published reports and indicate that this method of depletion primarily affects peripheral monocyte populations, especially the inflammatory monocyte compartment (Fig. S4, available at ) (49).
###end p 26
###begin p 27
###xml 0 48 0 48 <bold xmlns:xlink="http://www.w3.org/1999/xlink">C-L liposomes do not enter the WNV-infected CNS.</bold>
###xml 771 772 771 772 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 31 34 <span type="species:ncbi:11082?0.9877551020408163">WNV</span>
###xml 131 135 <span type="species:ncbi:10090">mice</span>
###xml 333 336 <span type="species:ncbi:11082?0.9877551020408163">WNV</span>
###xml 391 394 <span type="species:ncbi:11082?0.9877551020408163">WNV</span>
###xml 638 642 <span type="species:ncbi:10090">mice</span>
###xml 785 788 <span type="species:ncbi:11082?0.9877551020408163">WNV</span>
###xml 1071 1074 <span type="species:ncbi:11082?0.9877551020408163">WNV</span>
###xml 1091 1096 <span type="species:ncbi:10090">mouse</span>
###xml 1150 1153 <span type="species:ncbi:11082?0.9877551020408163">WNV</span>
###xml 1496 1499 <span type="species:ncbi:11082?0.9877551020408163">WNV</span>
###xml 1509 1513 <span type="species:ncbi:10090">mice</span>
###xml 1528 1531 <span type="species:ncbi:11082?0.9877551020408163">WNV</span>
###xml 1541 1545 <span type="species:ncbi:10090">mice</span>
###xml 1661 1665 <span type="species:ncbi:10090">mice</span>
###xml 1809 1813 <span type="species:ncbi:10090">mice</span>
C-L liposomes do not enter the WNV-infected CNS. Liposomes loaded with clodronate were injected i.v. at day 7 p.i. and, 6 h later, mice were killed. Hematoxylin and eosin (H&E) staining of brain sections showed no perivascular cuffing in mock-infected animals (A and B). In contrast, distinct perivascular cuffs were observed in the WNV-infected C-L liposome-treated group (E and F) and the WNV-infected PBS liposome-treated group (I and J). To confirm that the cells within these cuffs were of myeloid lineage, we stained sections, consecutive to those stained with H&E, with lectin. Lectin staining in brain sections from mock-infected mice confirmed the absence of perivascular cuffing (C and D). In contrast, most of the cells within the perivascular cuff were lectin+ in both the WNV-infected C-L liposome-treated (G and H) and the PBS liposome-treated (K and L) groups. To further ensure that C-L liposomes used to deplete circulating monocytes did not enter the brain, we injected D-L liposomes at day 7 p.i. Dil was found in the marginal zones of mock- (M-P) and WNV (Q-T) -infected mouse spleens. However, no D-L liposomes were found in the WNV-infected brain (U-X) or the mock-infected brain (X, bottom left inset). Top right insets are higher power views of cells in representative fields. Depletion of monocytes from the blood compartment with C-L liposomes from 1 d before infection and then every other day onwards resulted in a significant reduction in the numbers of microglia in WNV-infected mice compared with WNV-infected mice treated with null liposomes or mock-treated, as detected by flow cytometry (Y). Data shown are from at least three mice per group and are representative. C-L liposome depletion data are means +/- SD and are representative of three experiments with at least three mice per group. *, P < 0.05 using a two-tailed T test. Bars: (A, C, E, G, I, K, and M-X) 200 muM; (B, D, F, H, J, L, and insets) 50 muM.
###end p 27
###begin p 28
###xml 318 326 318 326 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig3" ref-type="fig">Fig. 3 Y</xref>
###xml 33 36 <span type="species:ncbi:11082?0.9877551020408163">WNV</span>
###xml 46 50 <span type="species:ncbi:10090">mice</span>
###xml 237 240 <span type="species:ncbi:11082?0.9877551020408163">WNV</span>
###xml 250 254 <span type="species:ncbi:10090">mice</span>
###xml 547 550 <span type="species:ncbi:11082?0.9877551020408163">WNV</span>
Clodronate liposome treatment of WNV-infected mice 1 d before infection and then every other day onwards resulted in significantly reduced numbers of microglia in the brain, as detected using flow cytometry, on day 7 p.i., compared with WNV-infected mice without treatment or treated with nondepleting null liposomes (Fig. 3 Y). As C-L liposomes do not delete any myeloid cells behind the BBB but cause a significant reduction in the number of microglia in the brain, this strongly suggests that the increased numbers of microglia in the brain in WNV encephalitis are derived from blood monocytes.
###end p 28
###begin title 29
###xml 32 35 <span type="species:ncbi:11082?0.9877551020408163">WNV</span>
Increased microglial numbers in WNV infection are derived from the blood
###end title 29
###begin p 30
###xml 224 226 224 226 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib50">50</xref>
###xml 475 476 471 472 <sup xmlns:xlink="http://www.w3.org/1999/xlink">a</sup>
###xml 480 481 476 477 <sup xmlns:xlink="http://www.w3.org/1999/xlink">b</sup>
###xml 594 595 590 591 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 618 619 614 615 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 632 634 628 630 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib50">50</xref>
###xml 61 64 <span type="species:ncbi:11082?0.9877551020408163">WNV</span>
###xml 98 103 <span type="species:ncbi:10090">mouse</span>
###xml 326 330 <span type="species:ncbi:10090">mice</span>
###xml 399 403 <span type="species:ncbi:10090">mice</span>
###xml 496 500 <span type="species:ncbi:10090">mice</span>
To further investigate possible microglial precursors during WNV infection, we used the cFMS-EGFP mouse. cFMS is the colony stimulating factor receptor 1, CD115, and is largely restricted to cells of the macrophage lineage (50). Microglia in the normal brain are mostly quiescent and thus radio resistant. Therefore, chimeric mice were made, in which BM from C57BL/6-7.2fms-EGFP transgenic (CD45.2) mice was used to reconstitute gamma-irradiated C57BL/6 congenic B6.SJL-PtprcaPep3b/BoyJ (CD45.1) mice (Fig. S5, A-C, available at ). This chimera allowed us to differentiate between resident (GFP-) and infiltrating (GFP+) microglia (50).
###end p 30
###begin p 31
###xml 47 48 47 48 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 75 83 75 83 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig4" ref-type="fig">Fig. 4 A</xref>
###xml 105 106 105 106 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 139 147 139 147 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig4" ref-type="fig">Fig. 4 B</xref>
###xml 259 274 259 274 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig4" ref-type="fig">Fig. 4, G and H</xref>
###xml 277 278 277 278 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib7">7</xref>
###xml 462 463 462 463 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 513 528 513 528 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig4" ref-type="fig">Fig. 4, C and D</xref>
###xml 580 581 580 581 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 626 634 626 634 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig4" ref-type="fig">Fig. 4 C</xref>
###xml 757 765 757 765 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig4" ref-type="fig">Fig. 4 C</xref>
###xml 300 304 <span type="species:ncbi:10090">mice</span>
###xml 306 309 <span type="species:ncbi:11082?0.9877551020408163">WNV</span>
###xml 328 332 <span type="species:ncbi:10090">mice</span>
###xml 408 411 <span type="species:ncbi:11082?0.9877551020408163">WNV</span>
Histological examination revealed that both GFP+ perivascular macrophages (Fig. 4 A, white arrow) and GFP+ parenchymal ramified microglia (Fig. 4 B) accounted for a small percentage of cells in the mock-infected brain, which is consistent with previous work (Fig. 4, G and H) (7). Similar to C57BL/6 mice, WNV-infected chimeric mice developed encephalitis and were moribund by day 7 p.i. (unpublished data). WNV-infected cFMS-EGFP chimeras displayed numerous GFP+ cells in all regions of the brain by day 7 p.i. (Fig. 4, C and D). Of particular note, the distribution of these GFP+ cells was mostly within perivascular cuffs (Fig. 4 C and inset). In addition, cells nearest the center of the perivascular cuff appeared to have a round monocytic morphology (Fig. 4 C, inset, white arrow), whereas those nearer to the brain parenchyma on the periphery of the perivascular cuffs were more rod shaped (inset, red arrow), suggesting monocyte differentiation as cells enter the parenchyma.
###end p 31
###begin p 32
###xml 0 64 0 64 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Histology and flow cytometry of WNV-infected cFMS-EGFP chimeras.</bold>
###xml 129 130 125 126 <sup xmlns:xlink="http://www.w3.org/1999/xlink">a</sup>
###xml 134 135 130 131 <sup xmlns:xlink="http://www.w3.org/1999/xlink">b</sup>
###xml 224 225 220 221 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 298 299 294 295 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 515 516 511 512 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 674 675 670 671 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 740 741 736 737 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 850 851 846 847 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 856 857 852 853 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 959 960 955 956 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 976 979 972 975 <sup xmlns:xlink="http://www.w3.org/1999/xlink">int</sup>
###xml 1003 1005 999 1001 <sup xmlns:xlink="http://www.w3.org/1999/xlink">hi</sup>
###xml 1045 1046 1041 1042 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1100 1103 1096 1099 <sup xmlns:xlink="http://www.w3.org/1999/xlink">int</sup>
###xml 1122 1123 1118 1119 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1219 1220 1215 1216 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 1225 1227 1221 1223 <sup xmlns:xlink="http://www.w3.org/1999/xlink">lo</sup>
###xml 1341 1342 1337 1338 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1347 1350 1343 1346 <sup xmlns:xlink="http://www.w3.org/1999/xlink">int</sup>
###xml 1369 1370 1365 1366 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1571 1572 1565 1566 <italic xmlns:xlink="http://www.w3.org/1999/xlink">t</italic>
###xml 32 35 <span type="species:ncbi:11082?0.9877551020408163">WNV</span>
###xml 150 154 <span type="species:ncbi:10090">mice</span>
###xml 273 277 <span type="species:ncbi:10090">mice</span>
###xml 479 482 <span type="species:ncbi:11082?0.9877551020408163">WNV</span>
###xml 1167 1171 <span type="species:ncbi:10090">mice</span>
###xml 1289 1293 <span type="species:ncbi:10090">mice</span>
###xml 1414 1418 <span type="species:ncbi:10090">mice</span>
###xml 1519 1523 <span type="species:ncbi:10090">mice</span>
Histology and flow cytometry of WNV-infected cFMS-EGFP chimeras. Reconstitution of gamma-irradiated C57BL/6 congenic B6.SJL-PtprcaPep3b/BoyJ (CD45.1) mice with cFMS-EGFP BM resulted in chimeras in which a small number of GFP+ cells were present in the CNS of mock-infected mice. Histologically, GFP+ cells (white arrowheads) were usually seen around the perivascular space (A); however, a small number of ramified microglia expressing GFP were seen in the parenchyma (B). During WNV infection, a large influx of GFP+ cells was seen, in most cases located to the perivascular cuff (C, 20x magnification). Insets (100x magnification of the same field) show recruited round GFP+ cells near the vessel lumen (white arrowhead) and rod-shaped GFP+ cells closer to the parenchyma (red arrowhead). Gr1 (D, red) staining of chimeras clearly showed several Gr1+/cFMS+ cells in the brain (D, yellow). Using flow cytometry (E), it was clear that a large proportion of GFP+ cells were CD45int microglia (R2) and CD45hi macrophages (blue dots), as well as Gr1+ (F). Significantly more (approximately fourfold) CD45int microglia were GFP+ at day 7 p.i., compared with mock-infected mice (G), whereas there were significantly fewer GFP- CD45lo resting microglia at day 7 p.i., compared with mock-infected mice (H). Significantly more (at least fourfold) GFP+ CD45int microglia were Gr1+ at day 7 p.i., compared with mock-infected mice (I). Gr1 data shown are means +/- SD and are representative of four experiments with at least three mice per group (***, P < 0.001, two tailed unpaired t test). Bars: (A and D) 200 muM; (B and C) 100 muM; (insets) 50 muM.
###end p 32
###begin p 33
###xml 98 101 98 101 <sup xmlns:xlink="http://www.w3.org/1999/xlink">int</sup>
###xml 107 108 107 108 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 114 115 114 115 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 180 195 180 195 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig4" ref-type="fig">Fig. 4, E and G</xref>
###xml 257 258 257 258 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 332 347 332 347 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig4" ref-type="fig">Fig. 4, F and I</xref>
###xml 391 393 391 393 <sup xmlns:xlink="http://www.w3.org/1999/xlink">lo</sup>
###xml 399 400 399 400 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 406 407 406 407 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 467 468 467 468 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 571 579 567 575 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig4" ref-type="fig">Fig. 4 H</xref>
###xml 610 625 606 621 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig4" ref-type="fig">Fig. 4 (G and H</xref>
###xml 678 679 674 675 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 801 802 797 798 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 1033 1034 1029 1030 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1039 1042 1035 1038 <sup xmlns:xlink="http://www.w3.org/1999/xlink">int</sup>
###xml 437 440 <span type="species:ncbi:11082?0.9877551020408163">WNV</span>
###xml 544 547 <span type="species:ncbi:11082?0.9877551020408163">WNV</span>
###xml 723 726 <span type="species:ncbi:11082?0.9877551020408163">WNV</span>
###xml 736 740 <span type="species:ncbi:10090">mice</span>
###xml 830 834 <span type="species:ncbi:10090">mice</span>
###xml 981 984 <span type="species:ncbi:11082?0.9877551020408163">WNV</span>
###xml 1075 1078 <span type="species:ncbi:11082?0.9877551020408163">WNV</span>
###xml 1088 1093 <span type="species:ncbi:10090">mouse</span>
Flow cytometric analysis at day 7 p.i. confirmed that at least 50-75% of activated microglia (CD45int/CD11b+/CD11c-) expressed GFP, indicating that they were peripherally derived (Fig. 4, E and G). Furthermore, at this time point, 75% of these activated GFP+ microglia also expressed the inflammatory monocyte-associated Gr1 (Ly6C; Fig. 4, F and I). In contrast, most resting microglia (CD45lo/CD11b+/CD11c-) from both mock-infected and WNV-infected chimeras were GFP-, indicating that they were of resident origin (mock infected, 93 +/- 3.0%; WNV-infected, 88 +/- 3.9%; Fig. 4 H). Adding together the data in Fig. 4 (G and H, right), it can be seen that the total number of GFP- microglia (i.e., activated and resting) in WNV-infected mice was not significantly different from the total number of GFP- microglia in mock-infected mice. This suggests that proliferation of microglia in situ in the brain is unlikely to be the major mechanism for increased microglial numbers during WNV encephalitis. Furthermore, the proportion of GFP+ CD45int microglia expressing GR1 in the WNV-infected mouse supports the differentiation of these microglia from a blood-derived precursor, specifically the GR1-expressing inflammatory monocyte.
###end p 33
###begin title 34
###xml 27 29 27 29 <sup xmlns:xlink="http://www.w3.org/1999/xlink">hi</sup>
###xml 39 41 39 41 <sup xmlns:xlink="http://www.w3.org/1999/xlink">lo</sup>
Adoptively transferred Ly6chi, not Ly6Clo, cells traffic to the CNS within 12 h of transfer
###end title 34
###begin p 35
###xml 108 112 <span type="species:ncbi:10090">mice</span>
###xml 374 378 <span type="species:ncbi:10090">mice</span>
It has previously been reported that the ability of inflammatory monocytes to penetrate the CNS in chimeric mice is caused by irradiation preconditioning of the CNS. Therefore, because there was negligible breakdown of the BBB in this viral model, we further investigated the ability of inflammatory monocytes to penetrate the CNS using tracking techniques in nonirradiated mice.
###end p 35
###begin p 36
###xml 60 62 60 62 <sup xmlns:xlink="http://www.w3.org/1999/xlink">hi</sup>
###xml 68 69 68 69 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 79 80 79 80 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 86 87 86 87 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 121 123 121 123 <sup xmlns:xlink="http://www.w3.org/1999/xlink">lo</sup>
###xml 129 130 129 130 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 140 141 140 141 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 147 148 147 148 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 214 215 214 215 <sup xmlns:xlink="http://www.w3.org/1999/xlink">6</sup>
###xml 220 221 220 221 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 247 248 247 248 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 288 290 288 290 <sup xmlns:xlink="http://www.w3.org/1999/xlink">hi</sup>
###xml 308 309 308 309 <sup xmlns:xlink="http://www.w3.org/1999/xlink">6</sup>
###xml 314 315 314 315 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 341 342 341 342 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 381 383 381 383 <sup xmlns:xlink="http://www.w3.org/1999/xlink">lo</sup>
###xml 402 413 402 413 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig5" ref-type="fig">Fig. 5, A&#8211;D</xref>
###xml 508 519 508 519 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig5" ref-type="fig">Fig. 5, E&#8211;I</xref>
###xml 599 600 599 600 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 674 682 674 682 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig5" ref-type="fig">Fig. 5 F</xref>
###xml 724 732 724 732 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig5" ref-type="fig">Fig. 5 G</xref>
###xml 762 763 762 763 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 767 768 767 768 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 773 775 773 775 <sup xmlns:xlink="http://www.w3.org/1999/xlink">hi</sup>
###xml 854 862 854 862 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig5" ref-type="fig">Fig. 5 I</xref>
###xml 889 892 889 892 <sup xmlns:xlink="http://www.w3.org/1999/xlink">int</sup>
###xml 902 904 902 904 <sup xmlns:xlink="http://www.w3.org/1999/xlink">hi</sup>
###xml 919 920 919 920 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 970 978 970 978 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig5" ref-type="fig">Fig. 5 H</xref>
###xml 1001 1003 1001 1003 <sup xmlns:xlink="http://www.w3.org/1999/xlink">hi</sup>
###xml 1113 1114 1113 1114 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1119 1121 1119 1121 <sup xmlns:xlink="http://www.w3.org/1999/xlink">hi</sup>
###xml 1129 1130 1129 1130 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1135 1137 1135 1137 <sup xmlns:xlink="http://www.w3.org/1999/xlink">lo</sup>
###xml 1184 1201 1184 1201 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig5" ref-type="fig">Fig. 5, J and L&#8211;N</xref>
###xml 1239 1256 1239 1256 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig5" ref-type="fig">Fig. 5, K and O&#8211;Q</xref>
###xml 653 656 <span type="species:ncbi:11082?0.9877551020408163">WNV</span>
###xml 717 722 <span type="species:ncbi:10090">mouse</span>
###xml 950 953 <span type="species:ncbi:11082?0.9877551020408163">WNV</span>
###xml 1178 1182 <span type="species:ncbi:10090">mice</span>
###xml 1206 1209 <span type="species:ncbi:11082?0.9877551020408163">WNV</span>
###xml 1219 1223 <span type="species:ncbi:10090">mice</span>
First, we tested the ability of inflammatory monocytes (Ly6Chi/CD11b+/cFMS-EGFP+{CD115+}) and circulating monocytes (Ly6Clo/CD11b+/cFMS-EGFP+{CD115+}) to traffic to the CNS. To do this, we adoptively transferred 106 EGFP+/CMTMR-cell tracker orange+ BM-derived inflammatory monocytes (Ly6Chi) together with 106 EGFP+/CMTMR-cell tracker orange- BM-derived circulating monocytes (Ly6Clo) at day 6.5 p.i. (Fig. 5, A-D). 12 h later, the presence of these cells in the brain was investigated using flow cytometry (Fig. 5, E-I). Although recovery of adoptively transferred cells was low, the number of EGFP+ cells in the brain was significantly greater in the WNV-infected animal (Fig. 5 F, 0.03%) than in the mock-infected mouse (Fig. 5 G, 0.005%). Cell tracker orange+ GFP+ Ly6Chi cells comprised >90% of adoptively transferred cells isolated from the brain (Fig. 5 I). Interestingly, both CD45int- and CD45hi-expressing GFP+ cells were isolated from the WNV-infected brain (Fig. 5 H), suggesting that Ly6Chi precursors may differentiate into either microglia or macrophages. This was also seen when we transferred GFP+ Ly6Chi and GFP+ Ly6Clo monocytes separately into mock-infected mice (Fig. 5, J and L-N) or WNV-infected mice at day 6 p.i. (Fig. 5, K and O-Q).
###end p 36
###begin p 37
###xml 27 29 27 29 <sup xmlns:xlink="http://www.w3.org/1999/xlink">hi</sup>
###xml 0 74 0 74 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Adoptively transferred Ly6C<sup>hi</sup> monocytes traffic into the WNV-infected CNS.</bold>
###xml 79 81 79 81 <sup xmlns:xlink="http://www.w3.org/1999/xlink">hi</sup>
###xml 87 88 87 88 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 92 93 92 93 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 102 104 102 104 <sup xmlns:xlink="http://www.w3.org/1999/xlink">lo</sup>
###xml 110 111 110 111 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 115 116 115 116 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 208 210 208 210 <sup xmlns:xlink="http://www.w3.org/1999/xlink">hi</sup>
###xml 326 328 326 328 <sup xmlns:xlink="http://www.w3.org/1999/xlink">hi</sup>
###xml 333 335 333 335 <sup xmlns:xlink="http://www.w3.org/1999/xlink">lo</sup>
###xml 643 644 643 644 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 817 820 817 820 <sup xmlns:xlink="http://www.w3.org/1999/xlink">int</sup>
###xml 834 836 834 836 <sup xmlns:xlink="http://www.w3.org/1999/xlink">hi</sup>
###xml 848 850 848 850 <sup xmlns:xlink="http://www.w3.org/1999/xlink">hi</sup>
###xml 855 856 855 856 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 881 882 881 882 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 948 950 948 950 <sup xmlns:xlink="http://www.w3.org/1999/xlink">lo</sup>
###xml 955 956 955 956 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 981 982 981 982 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 57 60 <span type="species:ncbi:11082?0.9877551020408163">WNV</span>
###xml 164 167 <span type="species:ncbi:11082?0.9877551020408163">WNV</span>
###xml 187 202 <span type="species:ncbi:10090">transgenic mice</span>
###xml 374 377 <span type="species:ncbi:11082?0.9877551020408163">WNV</span>
###xml 387 391 <span type="species:ncbi:10090">mice</span>
###xml 430 434 <span type="species:ncbi:10090">mice</span>
###xml 449 453 <span type="species:ncbi:10090">mice</span>
###xml 523 526 <span type="species:ncbi:11082?0.9877551020408163">WNV</span>
###xml 536 540 <span type="species:ncbi:10090">mice</span>
###xml 573 576 <span type="species:ncbi:11082?0.9877551020408163">WNV</span>
###xml 681 684 <span type="species:ncbi:11082?0.9877551020408163">WNV</span>
###xml 694 698 <span type="species:ncbi:10090">mice</span>
###xml 920 923 <span type="species:ncbi:11082?0.9877551020408163">WNV</span>
###xml 1110 1113 <span type="species:ncbi:11082?0.9877551020408163">WNV</span>
###xml 1123 1127 <span type="species:ncbi:10090">mice</span>
###xml 1203 1207 <span type="species:ncbi:10090">mice</span>
Adoptively transferred Ly6Chi monocytes traffic into the WNV-infected CNS. Ly6Chi/CD11b+/GFP+ and Ly6Clo/CD11b+/GFP+ BM cells were sorted as shown (A-C) from day 6 WNV-infected cFMS-EGFP transgenic mice. Ly6Chi monocytes were labeled as described in Materials and methods with CTMR-cell tracker orange (D). A 1:1 ratio of Ly6Chi/Ly6Clo cells was intravenously injected into WNV-infected mice on day 6.5 p.i. or into mock-infected mice, whereas some mice received no cells. Leukocytes were isolated from the brains of these WNV-infected mice receiving no cells (E) and from WNV-infected (F) and mock-infected (G) brains 12 h after transfer. GFP+ cells were only found in the CNS of WNV-infected mice (F), with the adoptively transferred cells expressing differential levels of CD45 (H) as indicated by markers M1 (CD45int) and M2 (CD45hi). More Ly6Chi (GFP+/CTMR cell tracker orange+) BM cells were found to track to the WNV-infected brain than Ly6Clo (GFP+/CTMR-cell tracker orange-) BM cells (I). This was also observed when we injected these populations of cells separately into mock-infected (J and L-N) or WNV-infected mice (K and O-Q). Data are representative of two experiments with at least four mice per group. Bars, 50 muM.
###end p 37
###begin p 38
###xml 184 186 184 186 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib51">51</xref>
###xml 188 190 188 190 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib52">52</xref>
###xml 362 364 362 364 <sup xmlns:xlink="http://www.w3.org/1999/xlink">hi</sup>
###xml 410 421 410 421 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig6" ref-type="fig">Fig. 6, A&#8211;F</xref>
###xml 472 474 472 474 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib14">14</xref>
###xml 476 478 476 478 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib51">51</xref>
###xml 596 598 596 598 <sup xmlns:xlink="http://www.w3.org/1999/xlink">lo</sup>
###xml 629 644 629 644 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig6" ref-type="fig">Fig. 6, B and D</xref>
###xml 753 755 753 755 <sup xmlns:xlink="http://www.w3.org/1999/xlink">hi</sup>
###xml 783 798 783 798 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig6" ref-type="fig">Fig. 6, C and E</xref>
###xml 95 98 <span type="species:ncbi:11082?0.9877551020408163">WNV</span>
###xml 391 394 <span type="species:ncbi:11082?0.9877551020408163">WNV</span>
###xml 404 408 <span type="species:ncbi:10090">mice</span>
###xml 466 470 <span type="species:ncbi:10090">mice</span>
###xml 526 529 <span type="species:ncbi:11082?0.9877551020408163">WNV</span>
###xml 539 543 <span type="species:ncbi:10090">mice</span>
As a second test to confirm the role of inflammatory monocytes as microglial precursors during WNV encephalitis, we used an in vivo bead labeling system that was previously described (51, 52). Using clodronate liposome depletion at day 5.5 p.i. with FITC polystyrene bead injection 12 h later, we were able to recapitulate the stable labeling of circulating Ly6Chi inflammatory monocytes in WNV-infected mice (Fig. 6, A-F), as was previously described in uninfected mice (14, 51). In brief, injection of FITC beads alone into WNV-infected mice at day 6 p.i. resulted in the stable labeling of GR1lo monocytes in the circulation (Fig. 6, B and D). In contrast, prior C-L liposome-mediated depletion before bead infusion resulted in stable labeling of GR1hi or inflammatory monocytes (Fig. 6, C and E).
###end p 38
###begin p 39
###xml 44 46 44 46 <sup xmlns:xlink="http://www.w3.org/1999/xlink">lo</sup>
###xml 0 94 0 94 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Bead-labeled inflammatory monocytes, not GR1<sup>lo</sup> monocytes, traffic into the WNV-infected brain.</bold>
###xml 174 176 174 176 <sup xmlns:xlink="http://www.w3.org/1999/xlink">hi</sup>
###xml 213 215 213 215 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib14">14</xref>
###xml 217 219 217 219 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib51">51</xref>
###xml 293 294 293 294 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 429 431 429 431 <sup xmlns:xlink="http://www.w3.org/1999/xlink">lo</sup>
###xml 445 446 445 446 <sup xmlns:xlink="http://www.w3.org/1999/xlink">B</sup>
###xml 569 571 569 571 <sup xmlns:xlink="http://www.w3.org/1999/xlink">hi</sup>
###xml 598 601 598 601 <sup xmlns:xlink="http://www.w3.org/1999/xlink">C+B</sup>
###xml 641 643 641 643 <sup xmlns:xlink="http://www.w3.org/1999/xlink">hi</sup>
###xml 655 657 655 657 <sup xmlns:xlink="http://www.w3.org/1999/xlink">lo</sup>
###xml 687 688 687 688 <sup xmlns:xlink="http://www.w3.org/1999/xlink">B</sup>
###xml 695 698 695 698 <sup xmlns:xlink="http://www.w3.org/1999/xlink">C+B</sup>
###xml 885 887 885 887 <sup xmlns:xlink="http://www.w3.org/1999/xlink">lo</sup>
###xml 993 995 993 995 <sup xmlns:xlink="http://www.w3.org/1999/xlink">hi</sup>
###xml 1111 1112 1111 1112 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1168 1169 1168 1169 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 75 78 <span type="species:ncbi:11082?0.9877551020408163">WNV</span>
###xml 228 231 <span type="species:ncbi:11082?0.9877551020408163">WNV</span>
###xml 241 245 <span type="species:ncbi:10090">mice</span>
###xml 306 309 <span type="species:ncbi:11082?0.9877551020408163">WNV</span>
###xml 319 323 <span type="species:ncbi:10090">mice</span>
###xml 497 500 <span type="species:ncbi:11082?0.9877551020408163">WNV</span>
###xml 510 514 <span type="species:ncbi:10090">mice</span>
###xml 792 795 <span type="species:ncbi:11082?0.9877551020408163">WNV</span>
###xml 805 809 <span type="species:ncbi:10090">mice</span>
###xml 950 953 <span type="species:ncbi:11082?0.9877551020408163">WNV</span>
###xml 963 967 <span type="species:ncbi:10090">mice</span>
Bead-labeled inflammatory monocytes, not GR1lo monocytes, traffic into the WNV-infected brain. As a second method for trafficking monocytes, we stably labeled peripheral Ly6Chi monocytes, as previously described (14, 51) (A-F). WNV-infected mice receiving no FITC beads had no circulating bead+ cells (A). WNV-infected mice that received only beads with no prior macrophage depletion with C-L liposomes only had beads inside Ly6Clo monocytes (R2B; B and D). In contrast, C-L liposome depletion in WNV-infected mice before bead injection resulted in the labeling of Ly6Chi inflammatory monocytes (R2C+B; C, E). The successful labeling of Ly6Chi versus Ly6Clo is confirmed by overlaying R2B and R2C+B (F). Finally, when we looked for the presence of beads in microglia (gated as shown in G) in WNV-infected mice, we found none in the non-bead-treated group (H) or the group in which Ly6Clo peripheral monocytes were labeled with beads (I). However, in WNV-infected mice where we labeled the Ly6Chi monocyte population with beads after C-L depletion, we found microglia-containing FITC beads (J). Furthermore, bead+ microglia showed down-regulated GR1, compared with bead+ inflammatory monocytes (K), suggesting down-regulation upon entry in to the CNS. Finally, these bead-labeled monocyte-derived microglia had also up-regulated their expression of MHC-II (L) and CD86 (M) upon entry into the brain.
###end p 39
###begin p 40
###xml 180 181 180 181 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 186 189 186 189 <sup xmlns:xlink="http://www.w3.org/1999/xlink">int</sup>
###xml 195 196 195 196 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 202 203 202 203 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 229 237 229 237 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig6" ref-type="fig">Fig. 6 J</xref>
###xml 278 286 278 286 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig6" ref-type="fig">Fig. 6 H</xref>
###xml 333 341 333 341 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig6" ref-type="fig">Fig. 6 I</xref>
###xml 397 398 397 398 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 560 563 560 563 <sup xmlns:xlink="http://www.w3.org/1999/xlink">int</sup>
###xml 569 570 569 570 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 575 576 575 576 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 760 761 760 761 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 766 769 766 769 <sup xmlns:xlink="http://www.w3.org/1999/xlink">int</sup>
###xml 774 775 774 775 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 800 801 800 801 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 845 856 845 856 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig6" ref-type="fig">Fig. 6, I&#8211;K</xref>
###xml 896 897 896 897 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 953 954 953 954 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1057 1065 1057 1065 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig6" ref-type="fig">Fig. 6 K</xref>
###xml 1132 1133 1132 1133 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1162 1163 1162 1163 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 1171 1172 1171 1172 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1209 1224 1209 1224 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig6" ref-type="fig">Fig. 6, L and M</xref>
###xml 35 38 <span type="species:ncbi:11082?0.9877551020408163">WNV</span>
###xml 71 75 <span type="species:ncbi:10090">mice</span>
###xml 310 313 <span type="species:ncbi:11082?0.9877551020408163">WNV</span>
Flow cytometric examination of the WNV-infected brain at day 7 p.i. in mice where inflammatory monocytes were labeled with beads after C-L liposome treatment revealed a strong bead+/CD45int/CD11b+/CD11c- population of microglia (Fig. 6 J), which was absent in non-bead-treated (Fig. 6 H) and bead-only-treated WNV-infected controls (Fig. 6 I). This data clearly suggests that the migration of bead+ blood monocytes into the brain and subsequent differentiation into microglia is a very rapid event. As this has not been described, and to ensure that these CD45int/CD11b+ bead+ cells isolated from the brain were not just recently migrated nondifferentiated blood monocytes, we compared the expression of GR1, MHC-II, and the costimulation molecule CD86 on bead+ CD45intCD11b+ brain microglia and bead+ inflammatory monocytes in the circulation (Fig. 6, I-K). The pattern of GR1 expression on bead+ microglia was decreased, compared with circulating bead+ inflammatory monocytes, suggesting that Ly6C is down-regulated when monocytes enter the inflamed CNS (Fig. 6 K). Levels of both MHC-II and CD86, in contrast, were higher on bead+ microglia compared with bead- or bead+ circulating inflammatory monocytes (Fig. 6, L and M).
###end p 40
###begin p 41
###xml 484 486 484 486 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib12">12</xref>
###xml 488 490 488 490 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib34">34</xref>
###xml 121 125 <span type="species:ncbi:10090">mice</span>
###xml 198 201 <span type="species:ncbi:11082?0.9877551020408163">WNV</span>
These adoptive transfer and bead-tracking experiments demonstrate the traffic of inflammatory monocytes in nonirradiated mice and show clearly that the large burst of microglial numbers seen in the WNV-infected brain is caused by the recruitment of inflammatory monocytes and is not the result of radiation-induced changes in the CNS. Furthermore, these data show that inflammatory monocyte differentiation into microglia may occur in a shorter time frame than originally considered (12, 34).
###end p 41
###begin title 42
###xml 0 3 <span type="species:ncbi:11082?0.9877551020408163">WNV</span>
WNV infection triggers CCL2 production, which attracts inflammatory monocyte, microglial precursors
###end title 42
###begin p 43
###xml 61 63 61 63 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib15">15</xref>
###xml 65 67 65 67 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib16">16</xref>
###xml 322 330 322 330 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig7" ref-type="fig">Fig. 7 A</xref>
###xml 422 430 422 430 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig7" ref-type="fig">Fig. 7 A</xref>
###xml 472 480 472 480 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig7" ref-type="fig">Fig. 7 B</xref>
###xml 837 838 837 838 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 883 884 883 884 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 974 982 974 982 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig7" ref-type="fig">Fig. 7 B</xref>
###xml 135 138 <span type="species:ncbi:11082?0.9877551020408163">WNV</span>
###xml 161 164 <span type="species:ncbi:11082?0.9877551020408163">WNV</span>
###xml 587 590 <span type="species:ncbi:11082?0.9877551020408163">WNV</span>
###xml 959 962 <span type="species:ncbi:11082?0.9877551020408163">WNV</span>
CCL2 has been implicated in the egress of monocytes from BM (15, 16). We hypothesized that CCL2 may be involved in this process during WNV infection. Intranasal WNV infection of the CNS triggered the secretion of substantial amounts of CCL2 protein in the brain, beginning on day 5 and increasing until the time of death (Fig. 7 A). The kinetics of these high brain levels were mirrored by much lower levels in the serum (Fig. 7 A). Message for this chemokine is shown in Fig. 7 B (i) near perivascular cuffs by CCL2 mRNA in situ hybridization in the brain. Labeling for CCL2 protein in WNV-infected brains confirmed the presence of CCL2 protein at the perivascular cuff. However, costaining for viral antigen (NS-1), lectin, and CCL2 protein showed that many, though not all, virus-infected neurons and some uninfected neurons were CCL2+, whereas only occasional microglia were CCL2+, suggesting that viral-infected neurons are a major source of CCL2 during WNV infection (Fig. 7 B, ii-v).
###end p 43
###begin p 44
###xml 0 62 0 62 <bold xmlns:xlink="http://www.w3.org/1999/xlink">CCL2 protein kinetics and neutralization during WNV infection.</bold>
###xml 1096 1097 1096 1097 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1365 1367 1365 1367 <sup xmlns:xlink="http://www.w3.org/1999/xlink">hi</sup>
###xml 1853 1854 1851 1852 <italic xmlns:xlink="http://www.w3.org/1999/xlink">t</italic>
###xml 48 51 <span type="species:ncbi:11082?0.9877551020408163">WNV</span>
###xml 274 277 <span type="species:ncbi:11082?0.9877551020408163">WNV</span>
###xml 287 291 <span type="species:ncbi:10090">mice</span>
###xml 934 937 <span type="species:ncbi:11082?0.9877551020408163">WNV</span>
###xml 1195 1199 <span type="species:ncbi:10090">mice</span>
###xml 1201 1204 <span type="species:ncbi:10090">D-G</span>
###xml 1224 1227 <span type="species:ncbi:11082?0.9877551020408163">WNV</span>
###xml 1237 1241 <span type="species:ncbi:10090">mice</span>
###xml 1430 1433 <span type="species:ncbi:11082?0.9877551020408163">WNV</span>
###xml 1448 1452 <span type="species:ncbi:10090">mice</span>
###xml 1553 1557 <span type="species:ncbi:10090">mice</span>
###xml 1661 1665 <span type="species:ncbi:10090">mice</span>
###xml 1900 1903 <span type="species:ncbi:11082?0.9877551020408163">WNV</span>
###xml 1913 1917 <span type="species:ncbi:10090">mice</span>
CCL2 protein kinetics and neutralization during WNV infection. Using a multiplexed cytokine bead array, we measured both the serum and brain levels of CCL2. The level of CCL2 protein increased throughout infection in both brain and serum (A). CCL2 mRNA in the brain of five WNV-infected mice on day 7 p.i. was often localized to perivascular cuffs (B, i, black arrowheads). Fluorescent antibody labeling for CCL2 protein (red) and NS-1 (blue) showed that most cells expressing CCL2 were infected neurons (B, ii-iv; ii, white arrowheads). Not all infected neurons expressed CCL2 (B, ii and iii, white outlined arrowheads) and some uninfected neurons expressed CCL2. (B, v, white outlined arrowheads). The addition of lectin staining (green; B, iii-iv) showed that occasional perivascular microglia also expressed CCL2 faintly (B, iv, white arrowhead), whereas most microglia evidently did not (B, iii and v, white arrowheads). CCL2 in WNV-infected EGFP-cFMS chimeras was neutralized with intraperitoneal CCL2-neutralizing monoclonal antibody, resulting in a significant reduction in immigrant (GFP+) microglia at day 7 p.i. (C). We also determined whether this was also observed in nonirradiated mice (D-G). In nonirradiated WNV-infected mice, CCL2 neutralization (F) resulted in significantly reduced numbers of microglia, accounted for by drastic reduction in Ly6Chi-expressing cells (G), which was not observed in mock- (D) and WNV (E) -infected mice. Data shown are means +/- SD and are representative of at least two experiments with at least three mice per group. CCL2 broad array data are representative of three different experiments with at least three mice per group. Statistical analysis of CCL2 protein data was conducted using one-way ANOVA with a Tukey-Kramer post test. Neutralization experiments were analyzed using a two-tailed unpaired t test comparing neutralized to nonneutralized WNV infected mice. *, P < 0.05; ***, P < 0.001. Bars: (B, i) 200 muM; (B, ii-iv) 50 muM.
###end p 44
###begin p 45
###xml 295 303 295 303 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig7" ref-type="fig">Fig. 7 C</xref>
###xml 368 369 368 369 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 375 376 375 376 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 381 384 381 384 <sup xmlns:xlink="http://www.w3.org/1999/xlink">int</sup>
###xml 410 412 410 412 <sup xmlns:xlink="http://www.w3.org/1999/xlink">lo</sup>
###xml 731 742 731 742 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig7" ref-type="fig">Fig. 7, D&#8211;G</xref>
###xml 810 818 810 818 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig7" ref-type="fig">Fig. 7 G</xref>
###xml 885 887 885 887 <sup xmlns:xlink="http://www.w3.org/1999/xlink">hi</sup>
###xml 979 987 967 975 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig7" ref-type="fig">Fig. 7 G</xref>
###xml 554 557 <span type="species:ncbi:11082?0.9877551020408163">WNV</span>
###xml 567 571 <span type="species:ncbi:10090">mice</span>
###xml 712 715 <span type="species:ncbi:11082?0.9877551020408163">WNV</span>
###xml 725 729 <span type="species:ncbi:10090">mice</span>
###xml 739 742 <span type="species:ncbi:10090">D-G</span>
###xml 973 977 <span type="species:ncbi:10090">mice</span>
The data in the previous paragraph suggest that the CNS was the source of the serum CCL2 and that this induced the egress and observed migration of BM monocytes to the CNS. To test this, we injected CCL2-neutralizing antibody to inhibit both BM egress and CNS trafficking in cFMS-EGFP chimeras. Fig. 7 C shows a statistically significant reduction in the number of GFP+/CD11b+/CD45int (reduced to 31%) and CD45lo (reduced to 29%) immigrating microglia isolated from the CNS on day 7 p.i. after CCL2 neutralization, compared with isotype antibody-treated WNV-infected mice. This indicates that a major factor in the immigration of microglia is CCL2. This was not attributable to irradiation because nonirradiated WNV-infected mice (Fig. 7, D-G) also showed a reduction of up to 50% of total microglial numbers (Fig. 7 G). This reduction was mostly accounted for by the reduction of Ly6Chi microglia to approximately20% of the levels seen in control isotype antibody-treated mice (Fig. 7 G).
###end p 45
###begin p 46
###xml 66 67 66 67 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 73 74 73 74 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 145 156 145 156 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig8" ref-type="fig">Fig. 8, A&#8211;C</xref>
###xml 205 207 205 207 <sup xmlns:xlink="http://www.w3.org/1999/xlink">hi</sup>
###xml 312 314 312 314 <sup xmlns:xlink="http://www.w3.org/1999/xlink">lo</sup>
###xml 376 384 376 384 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig8" ref-type="fig">Fig. 8 D</xref>
###xml 423 425 423 425 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib15">15</xref>
###xml 488 490 488 490 <sup xmlns:xlink="http://www.w3.org/1999/xlink">hi</sup>
###xml 549 551 549 551 <sup xmlns:xlink="http://www.w3.org/1999/xlink">lo</sup>
###xml 570 578 570 578 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig8" ref-type="fig">Fig. 8 D</xref>
###xml 596 598 596 598 <sup xmlns:xlink="http://www.w3.org/1999/xlink">hi</sup>
###xml 39 43 <span type="species:ncbi:10090">mice</span>
###xml 295 299 <span type="species:ncbi:10090">mice</span>
###xml 681 684 <span type="species:ncbi:11082?0.9877551020408163">WNV</span>
###xml 694 698 <span type="species:ncbi:10090">mice</span>
###xml 918 922 <span type="species:ncbi:10090">mice</span>
###xml 1056 1059 <span type="species:ncbi:11082?0.9877551020408163">WNV</span>
This was further reflected in chimeric mice by the analysis of GFP+/CD11b+ monocytes in the blood and BM, using the gating strategy illustrated (Fig. 8, A-C). As expected, in the BM, significantly more Gr1hi cells were retained in the CCL2-neutralized compared with the isotype antibody-treated mice, whereas Gr1lo cells were not statistically different between these groups (Fig. 8 D, right), confirming previous studies (15). However, CCL2 neutralization significantly increased the GR1hi cell numbers in the blood but had little effect on the GR1lo monocyte numbers (Fig. 8 D, left). Thus, Gr1hi cells are evidently inhibited from immigrating into the brain in CCL2-neutralized WNV-infected mice, both at the level of the BBB and during egress from the BM. In contrast, over this short period of time (12 h), no changes were observed in blood and BM monocyte compartments after CCL2 neutralization of mock-infected mice (Fig. S6, available at ). This data indicates the importance of CCL2 in the trafficking of microglia from the BM to the brain during WNV encephalitis.
###end p 46
###begin p 47
###xml 34 36 34 36 <sup xmlns:xlink="http://www.w3.org/1999/xlink">hi</sup>
###xml 0 134 0 134 <bold xmlns:xlink="http://www.w3.org/1999/xlink">CCL2 neutralization sequesters Gr1<sup>hi</sup> monocytes in the BM and blood of WNV-infected mice and prolongs the life of WNV-infected animals.</bold>
###xml 528 530 528 530 <sup xmlns:xlink="http://www.w3.org/1999/xlink">hi</sup>
###xml 1049 1050 1047 1048 <italic xmlns:xlink="http://www.w3.org/1999/xlink">t</italic>
###xml 70 73 <span type="species:ncbi:11082?0.9877551020408163">WNV</span>
###xml 83 87 <span type="species:ncbi:10090">mice</span>
###xml 113 116 <span type="species:ncbi:11082?0.9877551020408163">WNV</span>
###xml 456 459 <span type="species:ncbi:11082?0.9877551020408163">WNV</span>
###xml 645 648 <span type="species:ncbi:11082?0.9877551020408163">WNV</span>
###xml 658 662 <span type="species:ncbi:10090">mice</span>
###xml 682 685 <span type="species:ncbi:11082?0.9877551020408163">WNV</span>
###xml 695 699 <span type="species:ncbi:10090">mice</span>
###xml 964 968 <span type="species:ncbi:10090">mice</span>
###xml 1096 1099 <span type="species:ncbi:11082?0.9877551020408163">WNV</span>
###xml 1109 1113 <span type="species:ncbi:10090">mice</span>
###xml 1243 1247 <span type="species:ncbi:10090">mice</span>
CCL2 neutralization sequesters Gr1hi monocytes in the BM and blood of WNV-infected mice and prolongs the life of WNV-infected animals. Monocyte populations in the BM (BM-derived monocyte) and peripheral blood (peripheral blood monocyte) were investigated by flow cytometry, based on the expression of EGFP-cFMS in conjunction with a cocktail of antibodies, including CD11b and CD45, using gating strategies indicated in A, B, and C. CCL2 neutralization in WNV-infected EGFP-cFMS chimeras resulted in significant increases in Gr1hi (inflammatory monocytes) in both the BM and peripheral blood (D), as well as significantly prolonging the life of WNV-infected mice (E), compared with WNV-infected mice either treated with isotype control mAb or PBS during infection. Plaque assays (F) showed that CCL2 neutralization had no significant impact on the viral titer on day 7 p.i. Data shown are means +/- SD and are representative of two different experiments with four mice per group. Neutralization experiments were analyzed using a two-tailed unpaired t test comparing neutralized to nonneutralized WNV-infected mice. *, P < 0.05; ***, P < 0.001. Kaplan-Meyer survival curves are representative of the results of two separate experiments with 10 mice per group in each. Data were analyzed using Prism Chi test (P < 0.001).
###end p 47
###begin title 48
CCL2 neutralization prolongs survival
###end title 48
###begin p 49
###xml 372 380 372 380 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig8" ref-type="fig">Fig. 8 E</xref>
###xml 499 507 499 507 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig8" ref-type="fig">Fig. 8 F</xref>
###xml 550 552 550 552 <sup xmlns:xlink="http://www.w3.org/1999/xlink">hi</sup>
###xml 56 60 <span type="species:ncbi:10090">mice</span>
###xml 195 199 <span type="species:ncbi:10090">mice</span>
###xml 319 323 <span type="species:ncbi:10090">mice</span>
###xml 446 449 <span type="species:ncbi:11082?0.9877551020408163">WNV</span>
###xml 459 463 <span type="species:ncbi:10090">mice</span>
###xml 601 604 <span type="species:ncbi:11082?0.9877551020408163">WNV</span>
###xml 700 703 <span type="species:ncbi:11082?0.9877551020408163">WNV</span>
In initial CCL2 neutralization experiments, neutralized mice displayed reduced disease-induced behaviors, including seizures, piloerection, and hunching (unpublished data). Treatment of infected mice with neutralizing antibody over several days resulted in significantly prolonged survival time, compared with infected mice receiving either isotype antibody or PBS alone (Fig. 8 E). Importantly, CCL2 neutralization had no effect on the titer of WNV in these mice, despite their increased survival (Fig. 8 F). This indicates that the immigrating Ly6Chi microglia arising from the BM are pathogenic in WNV encephalitis. Importantly, these data also discount a role for these cells in dissemination of WNV to the brain in this model.
###end p 49
###begin title 50
DISCUSSION
###end title 50
###begin p 51
###xml 312 314 312 314 <sup xmlns:xlink="http://www.w3.org/1999/xlink">hi</sup>
###xml 419 422 <span type="species:ncbi:11082?0.9877551020408163">WNV</span>
The role of monocyte trafficking as a mechanism for microglial cell replenishment has been debated for some time. This has been fueled by the inability to identify microglia from other macrophage populations found in diseased brains. Using several methods, we have highlighted a critical role for peripheral Ly6Chi inflammatory monocytes and the chemokine receptor ligand CCL2 in the ontogeny of microglia during fatal WNV infection of the brain.
###end p 51
###begin p 52
###xml 193 196 <span type="species:ncbi:11082?0.9877551020408163">WNV</span>
###xml 366 369 <span type="species:ncbi:11082?0.9877551020408163">WNV</span>
###xml 493 496 <span type="species:ncbi:11082?0.9877551020408163">WNV</span>
Although it is often argued that microglial proliferation is the mechanism behind increased microglial cell numbers seen during CNS inflammation, the low level of proliferation observed during WNV infection in conjunction with the ability of peripheral depletion of both classical and circulating monocytes to significantly reduce the numbers of microglial cells in WNV-infected brains at day 7 p.i. suggest that the recruitment of a peripheral microglial precursor plays an important role in WNV encephalitis.
###end p 52
###begin p 53
###xml 96 97 96 97 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib6">6</xref>
###xml 99 101 99 101 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib13">13</xref>
###xml 103 105 103 105 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib14">14</xref>
###xml 107 109 107 109 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib17">17</xref>
###xml 111 113 111 113 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib46">46</xref>
###xml 115 117 115 117 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib49">49</xref>
###xml 119 121 119 121 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib51">51</xref>
###xml 265 266 265 266 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib6">6</xref>
###xml 268 270 268 270 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib13">13</xref>
###xml 272 274 272 274 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib17">17</xref>
###xml 276 278 276 278 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib49">49</xref>
###xml 327 330 327 330 <sup xmlns:xlink="http://www.w3.org/1999/xlink">int</sup>
###xml 444 446 444 446 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib13">13</xref>
###xml 448 450 448 450 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib14">14</xref>
###xml 452 454 452 454 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib49">49</xref>
###xml 359 362 <span type="species:ncbi:11082?0.9877551020408163">WNV</span>
The peripheral blood contains two monocyte subsets, the inflammatory and circulating monocytes (6, 13, 14, 17, 46, 49, 51). Inflammatory monocytes are distinguished from circulating monocytes by their differential expression of the Ly6C portion of the Gr1 complex (6, 13, 17, 49). The similar expression of Ly6C on several CD45int microglia isolated from the WNV-infected brain implicates inflammatory monocytes as a microglial precursor pool (13, 14, 49).
###end p 53
###begin p 54
###xml 168 169 168 169 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib5">5</xref>
###xml 171 172 171 172 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib7">7</xref>
###xml 174 175 174 175 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib8">8</xref>
###xml 327 328 324 325 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib5">5</xref>
###xml 330 331 327 328 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib8">8</xref>
###xml 746 747 743 744 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 769 770 766 767 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 835 837 832 834 <sup xmlns:xlink="http://www.w3.org/1999/xlink">hi</sup>
###xml 858 864 855 861 <sup xmlns:xlink="http://www.w3.org/1999/xlink">lo/int</sup>
###xml 876 878 873 875 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib29">29</xref>
###xml 880 882 877 879 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib50">50</xref>
###xml 884 886 881 883 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib53">53</xref>
###xml 991 992 988 989 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1118 1121 1115 1118 <sup xmlns:xlink="http://www.w3.org/1999/xlink">int</sup>
###xml 1127 1128 1124 1125 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1131 1132 1128 1129 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1383 1384 1380 1381 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 541 545 <span type="species:ncbi:10090">mice</span>
BM chimeras have been successfully used to monitor microglial behavior in several disease models and allow for the differentiation of resident and immigrant microglia (5, 7, 8). However, these studies relied on the expression of beta-actin in donor BM in conjunction with IHC directed against antigens such as CD11b and IBA-1 (5, 8). As these antigens are expressed equally in macrophages and microglia, definitive identification of microglia and distinction from macrophages during inflammation is impossible. In the present study, BM from mice expressing EGFP on the cFMS promoter (CD115) were used as donors for chimeras. In conjunction with flow cytometry staining for CD45 antigen, this allowed us not only to delineate between resident (GFP-) and immigrating (GFP+) myeloid cells but also definitively to distinguish between CD45hi macrophages and CD45lo/int microglia (29, 50, 53). Infected cFMS-EGFP chimeras displayed widespread leukocyte recruitment at day 7 p.i. with numerous GFP+ cells displaying microglial morphology. Microglial cell recruitment from the periphery was confirmed by the abundance of CD45int CD11b+GFP+ microglia isolated from day 7 p.i. cFMS-EGFP chimeras by flow cytometry. Furthermore, we found that most of these microglia expressed Gr1 at similar levels to those seen on circulating inflammatory monocytes, whereas a large majority of resident (GFP-) microglia did not.
###end p 54
###begin p 55
###xml 145 147 145 147 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib10">10</xref>
###xml 176 178 176 178 <sup xmlns:xlink="http://www.w3.org/1999/xlink">hi</sup>
###xml 350 352 350 352 <sup xmlns:xlink="http://www.w3.org/1999/xlink">hi</sup>
###xml 443 445 443 445 <sup xmlns:xlink="http://www.w3.org/1999/xlink">lo</sup>
###xml 768 770 768 770 <sup xmlns:xlink="http://www.w3.org/1999/xlink">hi</sup>
###xml 901 903 901 903 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib14">14</xref>
###xml 905 907 905 907 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib49">49</xref>
###xml 207 210 <span type="species:ncbi:11082?0.9877551020408163">WNV</span>
###xml 241 245 <span type="species:ncbi:10090">mice</span>
###xml 407 410 <span type="species:ncbi:11082?0.9877551020408163">WNV</span>
It has been shown that irradiation of the CNS may alter patterns of monocyte trafficking into the brain in synthetic models of CNS inflammation (10). Therefore, ability of Ly6Chi monocytes to traffic to the WNV-infected CNS in nonirradiated mice was confirmed using two different tracking techniques. First, we showed that adoptively transferred Ly6Chi BM-derived monocytes trafficked preferentially to the WNV-infected CNS, compared with Ly6Clo BM-derived monocytes. Although it may be argued that the use of BM-derived monocytes rather than blood-derived monocytes may skew the interpretation of our results, it is important to note that the outcome of the experiment further supports the role of inflammatory monocytes as microglial precursors. This is because Ly6Chi inflammatory monocytes also act as precursors for circulating monocytes, in which case they down-regulate Ly6C as they circulate (14, 49).
###end p 55
###begin p 56
###xml 35 37 35 37 <sup xmlns:xlink="http://www.w3.org/1999/xlink">hi</sup>
###xml 98 100 98 100 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib14">14</xref>
###xml 590 592 590 592 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib10">10</xref>
###xml 832 834 832 834 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib54">54</xref>
###xml 836 838 836 838 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib55">55</xref>
###xml 1039 1041 1039 1041 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib56">56</xref>
###xml 1043 1045 1043 1045 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib57">57</xref>
###xml 119 122 <span type="species:ncbi:11082?0.9877551020408163">WNV</span>
###xml 189 192 <span type="species:ncbi:11082?0.9877551020408163">WNV</span>
###xml 449 452 <span type="species:ncbi:11082?0.9877551020408163">WNV</span>
###xml 1197 1201 <span type="species:ncbi:10090">mice</span>
Furthermore, we stably labeled Ly6Chi inflammatory monocytes using a previously described method (14). We found during WNV encephalitis that FITC bead-labeled monocytes trafficked into the WNV-infected brain and developed a microglial phenotype, as determined by the expression of CD45, MHC-II, and CD86. Therefore, these data not only clearly show that inflammatory monocytes, rather than circulating monocytes, act as microglial precursors during WNV encephalitis but that inflammatory monocyte migration into the CNS does not require radiation preconditioning or obvious BBB disruption (10). Although our data conflict with previous reports showing that irradiation plays a critical role in the migration of monocyte-derived microglia, other studies suggest that irradiation does not cause any pathological changes in the brain (54, 55). Furthermore, the employment of head protection during irradiation not only protects the CNS from irradiation but also the large volume of blood within the brain, as well as the BM within the skull (56, 57). Although it remains to be seen what role these elements play in trafficking of monocytes into the brain, the findings outlined here in nonirradiated mice indicate that inflammatory monocyte trafficking is an event triggered by viral encephalitis, a scenario that has not previously been explored in this context.
###end p 56
###begin p 57
###xml 119 120 119 120 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 122 123 122 123 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1</sub>
###xml 232 233 232 233 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 235 236 235 236 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1</sub>
###xml 301 303 301 303 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib58">58</xref>
###xml 374 375 374 375 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 377 378 377 378 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1</sub>
###xml 378 379 378 379 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 60 63 <span type="species:ncbi:11082?0.9877551020408163">WNV</span>
###xml 77 81 <span type="species:ncbi:10090">mice</span>
Finally, similar increases in microglia are observed during WNV infection in mice devoid of the fractalkine receptor CX3CR1 (unpublished data), which further implicates inflammatory monocytes as microglial precursors. However, as CX3CR1 is expressed constitutively by resident microglia in the brain (58), further investigation into the relationship between microglia and CX3CR1+-circulating monocytes is needed.
###end p 57
###begin p 58
###xml 108 110 108 110 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib15">15</xref>
###xml 112 114 112 114 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib16">16</xref>
###xml 255 256 255 256 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 440 441 440 441 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 621 623 621 623 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib15">15</xref>
###xml 625 627 625 627 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib16">16</xref>
###xml 117 120 <span type="species:ncbi:11082?0.9877551020408163">WNV</span>
###xml 270 273 <span type="species:ncbi:11082?0.9877551020408163">WNV</span>
###xml 486 489 <span type="species:ncbi:11082?0.9877551020408163">WNV</span>
The trafficking of inflammatory monocytes has been linked to the expression of CCR2 and production of CCL2 (15, 16). WNV infection of the CNS resulted in significant amounts of CCL2 production. Neutralization of CCL2 resulted in a massive reduction of GFP+ microglia in WNV-infected brains, clearly showing that the migration of inflammatory monocytes into the CNS is directed in part by the CCL2-CCR2 axis. However, the small number of GFP+ cells that are still found to penetrate the WNV-infected brain after CCL2 neutralization suggests that the other CCR2 ligands, CCL7 and CCL12, may also play a role in this model (15, 16).
###end p 58
###begin p 59
###xml 186 188 186 188 <sup xmlns:xlink="http://www.w3.org/1999/xlink">hi</sup>
###xml 380 382 380 382 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib15">15</xref>
###xml 384 386 384 386 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib16">16</xref>
###xml 790 792 790 792 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib15">15</xref>
###xml 61 64 <span type="species:ncbi:11082?0.9877551020408163">WNV</span>
Investigation into the effects of CCL2 neutralization during WNV encephalitis on BM and circulating monocyte populations showed that CCL2 neutralization resulted in the retention of Ly6Chi monocytes both in the BM and circulating blood. This suggests, as shown previously in peripheral nonviral models, that CCL2 acts both at the level of BM egress and also at the BBB interface (15, 16). It appears that the single-pulse antibody-mediated systemic reduction of the very high levels of CCL2, in the face of the high throughput of monocytes from the BM to the brain at this time point, may reduce immigration of monocytes into the brain before the effect of BM egress is apparent, causing an increase in blood monocyte numbers, which is in contrast to the effect of genetic absence of CCL2 (15).
###end p 59
###begin p 60
###xml 25 26 25 26 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 30 31 30 31 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 102 104 102 104 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib21">21</xref>
###xml 106 108 106 108 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib22">22</xref>
###xml 305 307 305 307 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib21">21</xref>
###xml 309 311 309 311 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib22">22</xref>
###xml 313 315 313 315 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib59">59</xref>
###xml 317 319 317 319 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib60">60</xref>
###xml 425 427 425 427 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib61">61</xref>
###xml 502 504 502 504 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib45">45</xref>
###xml 659 661 659 661 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib61">61</xref>
###xml 663 665 663 665 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib62">62</xref>
###xml 1128 1130 1128 1130 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib61">61</xref>
###xml 1132 1134 1132 1134 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib62">62</xref>
###xml 89 92 <span type="species:ncbi:11082?0.9877551020408163">WNV</span>
###xml 196 201 <span type="species:ncbi:9796">horse</span>
###xml 219 222 <span type="species:ncbi:11082?0.9877551020408163">WNV</span>
###xml 368 371 <span type="species:ncbi:11082?0.9877551020408163">WNV</span>
###xml 534 537 <span type="species:ncbi:11082?0.9877551020408163">WNV</span>
###xml 880 884 <span type="species:ncbi:10090">mice</span>
###xml 1033 1036 <span type="species:ncbi:11082?0.9877551020408163">WNV</span>
The infiltration of CD11b+CD45+ myeloid cells has been implicated in the pathogenesis of WNV disease (21, 22). This has been argued to be because of infected infiltrating cells acting in a Trojan horse manner, enabling WNV entry from the periphery into the brain in association with breakdown of the BBB (21, 22, 59, 60). However, more recently it has been shown that WNV entry into the CNS is mediated via axonal transport (61), and integrity of the BBB does not necessarily predict disease outcomes (45). In our model of intranasal WNV infection, infectious virus can be isolated from the brain several days (day 3 p.i) before monocyte infiltration occurs (61, 62), which is consistent with the expression of CCL2 by infected neurons attracting monocytes into the brain from the bloodstream. Therefore, the observation that CCL2 neutralization prolongs the survival of infected mice, although apparently having no effect on viral titer, suggests that inflammatory monocyte-derived microglia are likely to play a pathogenic role in WNV encephalitis, which is not simply explained by their possible role in viral dissemination (61, 62).
###end p 60
###begin p 61
###xml 871 873 871 873 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib63">63</xref>
###xml 48 51 <span type="species:ncbi:11082?0.9877551020408163">WNV</span>
It could be argued that the intranasal model of WNV infection is irrelevant in not mimicking natural infection. However, in all the published models of peripheral inoculation, the significant peripheral immune activation makes it impossible to separate the contribution of the systemic immune response to brain pathology that leads to death from the direct contribution of systemic immune response to death, independently of brain involvement. This is an important distinction that needs to inform interventional approaches to disease. The necessity of distinguishing experimentally between pathological events in the periphery and those in the brain has directed our development of this model. Furthermore, this distinction is likely to explain why macrophage deletion in peripheral inoculation results in enhanced mortality, whereas in our model it increases survival (63).
###end p 61
###begin p 62
###xml 539 541 539 541 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib62">62</xref>
###xml 1150 1152 1150 1152 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib19">19</xref>
###xml 64 67 <span type="species:ncbi:11082?0.9877551020408163">WNV</span>
###xml 263 266 <span type="species:ncbi:11082?0.9877551020408163">WNV</span>
###xml 534 537 <span type="species:ncbi:11082?0.9877551020408163">WNV</span>
###xml 934 937 <span type="species:ncbi:11082?0.9877551020408163">WNV</span>
The exact role of microglia in immune-mediated pathology during WNV infection requires further investigation. Although it is likely that microglia secrete numerous proinflammatory cytokines, because we have shown the importance of glutamate excitotoxicity during WNV infection, we suggest that pathogenic functions of microglia may reside in differential roles of immigrant and resident microglia in regulating neuronal function. Although much work is required to prove this, when considering the exclusively neuronal localization of WNV (62) and the importance of microglia in regulating the neurological environment, it is not unreasonable to speculate that inflammatory monocyte-derived microglia may play a pathogenic role in this phenomenon. Our data cannot definitively rule out an important role for macrophages (that are also likely to be derived from inflammatory monocytes) or CCR2-expressing T cells in the pathogenesis of WNV encephalitis. However, work conducted by several independent groups suggests that macrophages and T cells, recruited in a CCR5-dependent manner, are important in viral clearance and do not drive immunopathology (19).
###end p 62
###begin p 63
###xml 393 397 <span type="species:ncbi:10090">mice</span>
###xml 483 486 <span type="species:ncbi:11082?0.9877551020408163">WNV</span>
In conclusion, this is the first study to show that microglia are derived from inflammatory monocytes using CCL2 during a fatal model of flaviviral encephalitis. These exogenously derived microglia appear to bolster the endogenous microglial population. This CCL2-dependent migration appears to play a role in the pathogenesis of disease, as CCL2 neutralization prolonged the life of infected mice. The role of infiltrating inflammatory monocytes in mediating immunopathology during WNV encephalitis requires further investigation; however, their peripheral location before migration to the brain suggests that modulating these cells may serve as a novel therapy, not only during encephalitic disease but during other CNS disorders also.
###end p 63
###begin title 64
MATERIALS AND METHODS
###end title 64
###begin title 65
Virus propagation.
###end title 65
###begin p 66
###xml 25 27 25 27 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib62">62</xref>
###xml 30 33 <span type="species:ncbi:11082?0.9877551020408163">WNV</span>
###xml 85 89 <span type="species:ncbi:10090">mice</span>
As previously described (62), WNV (Sarafend) was derived from the brains of neonatal mice, which were used to infect confluent vero cell monolayers, at a multiplicity of infection of 5 PFU per cell. Infected cells were incubated for 40 h, after which they were frozen. Flasks were then thawed and the virus-rich supernatant clarified by centrifugation, after which aliquots were stored at -70degreesC until use.
###end p 66
###begin title 67
###xml 0 4 <span type="species:ncbi:10090">Mice</span>
Mice and infection.
###end title 67
###begin p 68
###xml 61 62 61 62 <sup xmlns:xlink="http://www.w3.org/1999/xlink">a</sup>
###xml 66 67 66 67 <sup xmlns:xlink="http://www.w3.org/1999/xlink">b</sup>
###xml 123 127 <span type="species:ncbi:10090">mice</span>
8-16-wk-old female C57BL/6 (CD45.2) and congenic B6.SJL-PtprcaPep3b/BoyJ (CD45.1), C57BL/6-7.2fms-EGFP transgenic (CD45.2) mice were obtained from the Blackburn animal house (University of Sydney, Sydney, Australia) or the Animal Resources Center (Western Australia). All procedures were performed with permission of the University of Sydney Animal Ethics Committee. All animals were housed under class II biohazard conditions in hepa filter-top cages. Food and water was provided ad libitum.
###end p 68
###begin p 69
###xml 74 75 74 75 <sup xmlns:xlink="http://www.w3.org/1999/xlink">4</sup>
###xml 178 180 178 180 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib62">62</xref>
###xml 182 184 182 184 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib64">64</xref>
###xml 64 67 <span type="species:ncbi:11082?0.9877551020408163">WNV</span>
Intranasal infection was conducted as previously described with WNV 6 x 104 PFU in sterile PBS (Invitrogen). Sham infections were conducted by inoculating with sterile PBS only (62, 64).
###end p 69
###begin p 70
###xml 0 4 <span type="species:ncbi:10090">Mice</span>
###xml 58 62 <span type="species:ncbi:10090">mice</span>
Mice were killed using cardiac perfusion of anaesthetised mice with 40 ml of ice-cold PBS followed by perfusion with 20 ml of 4% PFA (Sigma-Aldrich) in PBS for histology or 50 ml PBS only for flow cytometry.
###end p 70
###begin title 71
Plaque assay to determine viral titer.
###end title 71
###begin p 72
###xml 715 719 <span type="species:ncbi:10090">mice</span>
A virus plaque assay with virally susceptible BHK cells (donated by G. Karupiah, John Curtin Medical School, Canberra, Australia) was used. Tissue samples were dissected from animals and were immediately frozen in liquid nitrogen. 10% (wt/vol) tissues homogenates were prepared in Roswell Park Memorial Institute 1640 media (RPMI; CSL Biosciences) immediately before virus titration. In brief, thawed tissue samples were weighed in 2-ml screw cap tubes (SARSTEDT) before being disassociated with a power homogenizer (Tissue Tearor; BioSpec). The homogenates were then clarified by centrifugation at 1,500 rpm for 5 min at 4degreesC. The homogenate supernatant was used to infect BHK cells. Blood was collected from mice via the brachial artery. The samples were allowed to sit at 4degreesC for 8 h to coagulate before serum and plasma were separated by a high-speed 12,000 rpm centrifugation at 4degreesC. Supernatant serum was collected from centrifuged samples and stored in aliquots at -70degreesC.
###end p 72
###begin p 73
###xml 50 51 50 51 <sup xmlns:xlink="http://www.w3.org/1999/xlink">6</sup>
###xml 114 115 108 109 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
BHK cells were seeded into 6-well plates at 1 x 106 cells per well in 2 ml RPMI overnight at 37degreesC in a 5% CO2 incubator. Media was removed from the cells and replaced with 150 mul of virus samples at various dilutions. For tissue samples, fivefold dilutions were prepared, whereas serum samples were titrated twofold only. One well per plate was reserved as a negative control. Plates were incubated and rocked every 15 min for 1 h at 37degreesC. The inoculum was removed by aspiration and the wells overlaid with 3 ml of 1.5% (wt/vol) low-gelling Agarose II (Amresco) in 2x MEM (Invitrogen). The agarose plugs were allowed to solidify before plates were incubated for a further 3 d at 37degreesC. After this period, wells were fixed with 3 ml of 10% formalin (Sigma-Aldrich) for 2 h before agarose plug removal. Fixation was necessary to kill free virus and to harden the agarose plug to facilitate removal. A 3% crystal violet (Hopkins and Williams) dye solution in 20% methanol (Fronine) was used to stain fixed cells. Excess crystal violet was washed off with PBS. Plates were dried overnight before plaques were counted using a colony counter (IUL, S. A.). The final PFU per gram (tissue) or milliliter (serum) was determined by factoring the number of plaques, the inoculum volume, and the dilution.
###end p 73
###begin title 74
###xml 23 27 <span type="species:ncbi:10090">mice</span>
Generation of chimeric mice.
###end title 74
###begin p 75
###xml 135 136 135 136 <sup xmlns:xlink="http://www.w3.org/1999/xlink">7</sup>
###xml 44 48 <span type="species:ncbi:10090">mice</span>
###xml 104 108 <span type="species:ncbi:10090">mice</span>
###xml 181 185 <span type="species:ncbi:10090">Mice</span>
###xml 336 340 <span type="species:ncbi:10090">mice</span>
###xml 360 363 <span type="species:ncbi:11082?0.9877551020408163">WNV</span>
###xml 380 384 <span type="species:ncbi:10090">Mice</span>
6-8-wk-old B6.SJL-PtprcaPep3b/BoyJ (CD45.1) mice were irradiated with one dose of 950 rads. 12 h later, mice were reconstituted with 107 donor BM cells from C57BL/6-7.2fms-EGFP BM. Mice were given sulfamethoxazole (Sigma-Aldrich) and trimethoprim (Sigma-Aldrich) in drinking water for 10 d after irradiation. 6-12 wk after irradiation, mice were infected with WNV as described in Mice and infection. Chimerism was checked using flow cytometry and was invariably found to be 96-99% of donor origin (Fig. S5).
###end p 75
###begin title 76
Clodronate liposome depletion and FITC bead labeling of circulating monocytes.
###end title 76
###begin p 77
###xml 117 119 117 119 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib65">65</xref>
###xml 120 122 120 122 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib67">67</xref>
###xml 269 271 269 271 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib65">65</xref>
###xml 272 274 272 274 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib67">67</xref>
###xml 391 394 <span type="species:ncbi:11082?0.9877551020408163">WNV</span>
As previously shown, clodronate-encapsulated liposomes is an efficient method for depleting circulating macrophages (65-67). Clodronate was a gift of Roche. It was encapsulated in liposomes as described previously, and PBS-encapsulated liposomes were used as controls (65-67). Macrophages were depleted with multiple injections of clodronate-encapsulated liposomes on days 1, 3, and 5 after WNV infection. In the case of liposome tracking experiments, liposomes containing PBS were labeled with Dil (Invitrogen) and injected intravenously on day 7 p.i.
###end p 77
###begin p 78
###xml 67 69 67 69 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib14">14</xref>
###xml 71 73 71 73 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib50">50</xref>
To label circulating monocytes, the previously described protocol (14, 50) was modified. C-L liposomes were injected i.v. on day 5.5 p.i. 12 h later, a second i.v. injection of FITC Flouresbrite polystyrene beads (Polyscience) diluted 1:25 in PBS was given. Control nonclodronate liposome treatment groups injected with PBS only or beads only were also used.
###end p 78
###begin title 79
Immunohistology.
###end title 79
###begin p 80
###xml 25 27 25 27 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib62">62</xref>
As previously described (62), perfused brains and spleens were processed into paraffin blocks for sectioning. Sagittal 8-mum sections were cut for both routine H&E staining and IHC.
###end p 80
###begin p 81
###xml 74 76 74 76 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib62">62</xref>
###xml 317 319 317 319 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib62">62</xref>
###xml 22 25 <span type="species:ncbi:11082?0.9877551020408163">WNV</span>
###xml 250 253 <span type="species:ncbi:11082?0.9877551020408163">WNV</span>
Antigen retrieval for WNV labeling was conducted as previously described (62). Antigen retrieval for lectin labeling was conducted using citrate buffer in a microwave oven set on 600 W for 8 min and allowed to cool for 25 min. Staining protocols for WNV antigen and lectin were identical and as previously described (62).
###end p 81
###begin p 82
###xml 434 436 427 429 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib62">62</xref>
Fluorescence IHC was performed for the Gr1 complex with biotinylated Gr1 antibody (BioLegend) on cFMS-EGFP chimeras. In this case, brain tissue was fixed in 4% PFA at 4degreesC for 4 h and then immersed in 30% sucrose overnight, before being frozen in optimum cutting temperature compound (OCT; Tissue-Tek). 8-mum tissue sections were cut on a cryostat microtome and air dried. Fluorescence IHC was performed as previously described (62) with the addition of a tyramide-based amplification system (TSA kit; PerkinElmer) used according to the manufacturer's instructions.
###end p 82
###begin p 83
The presence of D-L liposomes was investigated on frozen 8-mum brain and spleen sections. In addition, slides were incubated with FITC-conjugated lectin (Sigma-Aldrich) for 60 min before counter stain with DAPI antifade (Vector Laboratories).
###end p 83
###begin title 84
BrdU incorporation.
###end title 84
###begin p 85
###xml 266 268 266 268 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib68">68</xref>
###xml 31 35 <span type="species:ncbi:10090">mice</span>
To detect proliferating cells, mice received 75 mg/kg BrdU (Becton Dickinson) i.v. 3 h before sacrifice on days 6 and 7 p.i. Proliferating cells were detected in situ by IHC using an anti-BrdU antibody on paraffin-embedded tissues (Skybio), as previously described (68). BrdU-positive cells were enumerated throughout the entire brain parenchyma on eight brains, two sections per brain, at days 6 and 7 p.i. from whole sagittal brain sections on double-blinded glass slides.
###end p 85
###begin title 86
Microscope and image acquisition.
###end title 86
###begin p 87
Images were acquired on a microscope (BX-51; Olympus), using a camera (DP-70; Olympus) and DP manager 2.2.1 software (Olympus).
###end p 87
###begin title 88
In-situ hybridization for CCL2.
###end title 88
###begin p 89
###xml 48 50 48 50 <sup xmlns:xlink="http://www.w3.org/1999/xlink">33</sup>
###xml 223 225 223 225 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib61">61</xref>
Paraffin-embedded sections were incubated with P33-labeled cRNA probes transcribed from linearized plasmid constructs containing the CCL2 cDNA and processed for in situ hybridization histochemistry as described previously (61).
###end p 89
###begin title 90
CNS leukocyte isolation.
###end title 90
###begin p 91
###xml 25 27 25 27 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib69">69</xref>
###xml 429 430 422 423 <italic xmlns:xlink="http://www.w3.org/1999/xlink">g</italic>
###xml 591 592 584 585 <italic xmlns:xlink="http://www.w3.org/1999/xlink">g</italic>
###xml 83 87 <span type="species:ncbi:10090">mice</span>
As previously described (69), leukocytes were obtained from the brains of infected mice by digesting brains in PBS with DNase (0.005 g/ml; Sigma-Aldrich) and collagenase IV (0.05 g/ml; Sigma-Aldrich) for 60 min at 37degreesC. Digestion was stopped with 10% FCS. The subsequent homogenate was passed through a nylon cell strainer with a 70-mum mesh size (Becton Dickinson). The pellet, obtained after 10-min centrifugation at 340 g, was resuspended in 30% percoll (GE Healthcare) and layered over 80% Percoll. Leukocytes were collected from the 30/80% interface after centrifugation at 1,140 g for 25 min at room temperature.
###end p 91
###begin title 92
BM-derived monocyte and peripheral blood monocyte isolation.
###end title 92
###begin p 93
###xml 333 334 332 333 <italic xmlns:xlink="http://www.w3.org/1999/xlink">g</italic>
###xml 390 391 389 390 <sub xmlns:xlink="http://www.w3.org/1999/xlink">4</sub>
###xml 393 394 392 393 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 459 460 458 459 <italic xmlns:xlink="http://www.w3.org/1999/xlink">g</italic>
###xml 669 670 668 669 <italic xmlns:xlink="http://www.w3.org/1999/xlink">g</italic>
###xml 811 812 810 811 <italic xmlns:xlink="http://www.w3.org/1999/xlink">g</italic>
###xml 192 196 <span type="species:ncbi:10090">mice</span>
For flow cytometry analysis, the right femur was dissecting out and BM cells flushed out using PBS-loaded syringes. In the case of BM precursor isolation, femurs and tibias from at least four mice were used. The cellular suspension achieved after flushing was filtered through a 70-mum cell strainer and centrifuged for 5 min at 340 g. The red cells in the resulting pellet were lysed in NH4Cl- red cell lysis buffer before being centrifuged for 5 min at 340 g. In the case of peripheral blood, blood was collected via cardiac puncture immediately into citrate buffer (mmol; Sigma-Alrich). The resulting suspension was layered over 30% percoll and centrifuged at 1,140 g for 20 min at room temperature with the brake off. The interface was collected and the cells were washed once in PBS and centrifuged at 340 g.
###end p 93
###begin title 94
Flow cytometry.
###end title 94
###begin p 95
###xml 314 321 314 321 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="tbl1">Table I</xref>
Cells collected as described in the previous section from brain, blood, or BM were then washed in PBS and blocked with anti-CD16/CD32 (BioLegend) antibody. Viable cells were counted using trypan blue exclusion, which routinely showed >95% cell viability. The antibodies utilized for flow cytometry are outlined in Table I.
###end p 95
###begin p 96
Antibodies used in this study
###end p 96
###begin p 97
###xml 48 49 48 49 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
FC, flow cytometry; Neut, neutralization; biotin+, biotinylated.
###end p 97
###begin p 98
Cell surface molecule expression was measured and cell sorts were performed on a FACS ARIA (Becton Dickinson), equipped with an Argon ion and HeNe laser. Viable populations were gated by forward and side scatter and identified fluorescent populations determined by forward-gating thereafter. Sorting was performed using specific fluorescent and scatter parameters identifying the population of interest. Sorting stringencies was set to purity to achieve >98% purity for BM populations.
###end p 98
###begin p 99
Acquired FACS data files were analyzed using the flow cytometry program Flow Jo (Tree Star, Inc.). Quantification of cell populations of interest were calculated based on flow cytometry percentages at analysis and absolute cell counts from each organ.
###end p 99
###begin title 100
Adoptive transfer.
###end title 100
###begin p 101
###xml 19 21 19 21 <sup xmlns:xlink="http://www.w3.org/1999/xlink">hi</sup>
###xml 31 32 31 32 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 38 39 38 39 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 48 50 48 50 <sup xmlns:xlink="http://www.w3.org/1999/xlink">lo</sup>
###xml 60 61 60 61 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 67 68 67 68 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 128 130 128 130 <sup xmlns:xlink="http://www.w3.org/1999/xlink">hi</sup>
###xml 516 518 515 517 <sup xmlns:xlink="http://www.w3.org/1999/xlink">hi</sup>
###xml 557 559 556 558 <sup xmlns:xlink="http://www.w3.org/1999/xlink">lo</sup>
###xml 642 644 641 643 <sup xmlns:xlink="http://www.w3.org/1999/xlink">hi</sup>
###xml 675 676 674 675 <sup xmlns:xlink="http://www.w3.org/1999/xlink">6</sup>
###xml 105 108 <span type="species:ncbi:11082?0.9877551020408163">WNV</span>
###xml 118 122 <span type="species:ncbi:10090">mice</span>
###xml 725 728 <span type="species:ncbi:11082?0.9877551020408163">WNV</span>
###xml 778 782 <span type="species:ncbi:10090">mice</span>
###xml 834 838 <span type="species:ncbi:10090">Mice</span>
We sorted both Ly6Chi/cFMS-EGFP+/CD11b+ and Ly6Clo/Cfms-EGFP+/CD11b+ populations from day 6 intranasally WNV-infected mice. Ly6Chi BM was labeled with 10 mM cell tracker orange (CMTMR [5-(and -6)-(((4-chloromethyl) benzoyl) amino) tetramethylrhodamine)-mixed isomers; Invitrogen). In brief, sorted cells were centrifuged and raised in 1 ml PBS containing 10 muM CMTMR. Cells were stained for 10 min before the reaction was stopped with 10% FCS. Cells were washed in 50 ml PBS at least three times. Labeled CMTMR Ly6Chi BM cells were then mixed 1:1 with Ly6Clo cells, which, except for the addition of CMTMR, had been treated similarly to Ly6Chi populations. A total of 2 x 106 BM cells were i.v. injected into either day 6.5 WNV-infected or mock-infected Ly5.1-C57BL/6 congenic mice. 12 h later, brains were harvested as described in Mice and infection and CNS leukocyte isolation, and the presence of donor cells was investigated using flow cytometry, both using cFMS-EGFP and CMTMR-cell tracker orange.
###end p 101
###begin title 102
CCL2 ELISA and neutralization.
###end title 102
###begin p 103
###xml 25 27 25 27 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib62">62</xref>
###xml 397 401 <span type="species:ncbi:10090">mice</span>
###xml 519 523 <span type="species:ncbi:10090">Mice</span>
As previously described (62), cytokine bead arrays (Becton Dickinson) were used to measure CCL2 protein concentration in both serum and brain homogenates according to the manufacturer's instructions. CCL2 neutralization was conducted by giving 100 mug CCL2 (clone: 2H5; BioLegend) or isotype control (Hamster IgG; BioLegend) antibody injections i.p. late on days 5 and 6 consecutively. Late day 7 mice were killed and perfused, and PBMS, BMMC, and infiltrating CNS leukocytes were prepared as described as described in Mice and infection and CNS leukocyte isolation.
###end p 103
###begin title 104
Statistics.
###end title 104
###begin p 105
###xml 206 207 206 207 <italic xmlns:xlink="http://www.w3.org/1999/xlink">t</italic>
Graphs were made and computerized statistical analysis was performed in Prism and InStat, respectively (both programs from GraphPad software, Inc.). Depending on the data, an unpaired, two-tailed Student's t test or one way ANOVA with a Tukey-Kramer post test was performed, with P < 0.05 considered to be significant.
###end p 105
###begin title 106
Online supplemental material.
###end title 106
###begin p 107
###xml 175 176 175 176 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 338 340 338 340 <sup xmlns:xlink="http://www.w3.org/1999/xlink">hi</sup>
###xml 349 351 349 351 <sup xmlns:xlink="http://www.w3.org/1999/xlink">lo</sup>
###xml 201 205 <span type="species:ncbi:10090">mice</span>
###xml 292 295 <span type="species:ncbi:11082?0.9877551020408163">WNV</span>
###xml 509 513 <span type="species:ncbi:10090">mice</span>
Fig. S1 shows Lectin and NS-1 IHC on day 7 p.i. throughout the brain. Fig. S2 shows control labeling for BrdU by flow cytometry in microglia and T cells in the brain and CD11b+ cells in BM in infected mice and in vitro-activated splenocytes. Fig. S3 shows Evans blue staining of the brain in WNV infection. Fig. S4 shows depletion of Ly6Chi and Ly6Clo monocytes in vivo by clodronate liposomes. Fig. S5 shows the purity of the cFMS-EGFP chimeras. Fig. S6 shows that acute CCL2 neutralization of mock-infected mice has no effect on monocyte populations. Online supplemental material is available at .
###end p 107
###begin p 108
We thank the members of the Blackburn animal house for their technical support and Barbara Hernandez for her time and help with histology in this paper.
###end p 108
###begin p 109
This study was funded by the National Health and Medical Research Council (NHMRC 253771 and 512413) to N.J.C. King and National Institutes of Health grants (NS036979 and NS044905) to I.L. Campbell. D.R. Getts was in receipt of an Australian Postgraduate Award during this study. M. Muller was a postdoctoral fellow supported by the Deutsche Forschungsgemeinschaft (Mu17-07/3-1) and was also supported by the Innovative Medical Research fund of the University of Munster Medical School, Germany.
###end p 109
###begin p 110
The authors do not have any conflicts of interest.
###end p 110

